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This thesis documented the study of liver fibrosis using non-linear optics mi-
croscopy. Rat fibrosis models were established as an animal platform, and tis-
sue level imaging was applied. To use non-linear optics methods to study liver 
fibrosis, images of unstained liver tissues taken were compared to convention-
al histological stained slice tissues. Four morphological features from digitized 
Second Harmonic Generation (SHG) / Two Photon Excitation Fluorescence 
(TPEF) images were extracted from tissues, and a standardized quantification 
system in liver fibrosis assessment was developed based on those features. Af-
ter comparing with the conventional ‘gold standard’ histopathological scoring 
system, we demonstrated the feasibility of SHG/TPEF microscopes in moni-
toring liver fibrosis progression by the quantitative assessment we developed. 
The quantitative and standardization nature of the SHG/TPEF imaging mo-
dalities allows for future application in diagnosis and prognostication of dis-
ease complications and to assist biopsy reading by minimizing the intra- and 
interobserver discrepancies through standardized features quantification for 
staging. The non-staining requirement of such imaging methods also gave the 
potential for in vivo fibrosis assessment given its ability to extract cellular lev-
el features. 
To achieve the goal of in vivo fibrosis assessment, we focused on the liver sur-
face, where the imaging scanning would be performed. Due to the limited in-
trinsic penetration depth of SHG/TPEF imaging modalities in opaque liver 
tissue, liver surface features were studies and compared to the general features 
we extracted in interior liver. We discovered a strong correlation between liver 
 iv 
fibrosis progression on the anterior surface and the interior based on quantita-
tive analysis of morphological features in both regions. By comparing with the 
conventional histopathological scoring system, we demonstrated the feasibility 
of monitoring liver fibrosis progression on the anterior liver surface. A uni-
form distribution of quantitative liver fibrotic features, such as total collagen 
distribution, bile duct proliferation and collagen in bile duct areas, was also 
discovered across two main lobes of the anterior liver surface, which gave us 
confidence to quantitatively monitor the progress of liver fibrosis on different 
lobe surfaces. 
Following the discovery that fibrosis distribution on liver surface is similar to 
that of the liver interior, application of such discovery was explored in live 
imaging. An intravital imaging-based liver chamber was designed and devel-
oped for the purpose of live rat imaging, and has been applied on both normal 
and fibrotic rats for in vivo liver fibrosis monitoring. A toxicity induced liver 
fibrosis model was developed as opposed to the previously used Bile Duct Li-
gation model, for the ease of chamber installation and imaging quality control. 
In live imaging of rat liver through a window chamber, we discovered similar 
fibrosis features to those we observed in both transmission and reflective tis-
sue imaging, including increase of capsule collagen distribution on liver sur-
face, increase of sub-capsule fibril collagen deposition within the liver tissue 
and disruption of tissue structure with the fibrosis progression. With these fea-
tures present in animal fibrosis models and the ability of detection of features 
in live imaging, we are currently able to monitor fibrosis based on this win-
dow animal model.
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Chapter 1 Introduction 
Liver fibrosis is a wound healing process occurring in response to almost all 
causes of chronic liver injury, and consists of an accumulation of fibrillar ex-
tracellular matrix (ECM) components [1, 2]. This process may lead to cirrho-
sis with its consequences of portal hypertension, hepatocellular carcinoma, 
and liver failure. The diagnosis and quantification of liver fibrosis, therefore, 
is critical for the treatment of the disease. Currently, percutaneous liver biopsy 
still represents the gold standard for the diagnosis and assessment of liver fi-
brosis [3]. However, besides the potential complications following liver biop-
sy, there are inherent drawbacks, such as invasive nature of the procedure, 
sampling error and inter- and intraobserver variability in the interpretation of 
the needle biopsy results [4, 5]. Intrinsic limited sensitivity and operator-
dependent variations also existed in the post procession of the extracted liver 
tissues. Meanwhile, histological examination does not predict disease progres-
sion [6]. 
Over recent years, Second harmonic generation (SHG) has emerged as a pow-
erful tool for imaging structural proteins in tissues [7]. Fibrillar collagen, be-
ing highly noncentrosymmetric, possesses a tremendous nonlinear susceptibil-
ity, therefore, SHG microscopy of collagen provide an invaluable tool for im-
aging tissue structure with submicron resolution [8]. Since its introduction by 
Denk et. al. [9], two-photon excited fluorescence (TPEF) has been widely 
used for imaging structure and dynamic interactions in biological tissues [10, 
11]. Since the major determinant of progressive fibrosis is the failure to de-
grade the increased fibril-forming scar matrix, especially the type Ι  collagen 
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[12], the principal collagen in fibrotic liver, SHG microscopy can be applied 
for targeting type Ι  collagen as a metric to indicate liver fibrosis. Combined 
SHG/TPEF images permit the location of SHG signals from collagen fibers 
within the liver, whose morphology is revealed by endogenous TPEF signals. 
Simultaneous three-dimensional visualization of collagen can be achieved and 
can be used to quantify fibrosis in fibrotic liver [13]. 
Based on these findings, in this thesis project, we aim to develop a fully auto-
mated liver fibrosis assessment system to quantify liver fibrosis based on the 
information extracted from images taken from unstained tissue slices. Second 
Harmonic Generation and Two Photon Excitation Fluorescence imaging mo-
dalities were employed to acquire those images, and computer-based imaging 
processing methods were explored for feature recognition and extraction. The 
assessment system was also compared with well-recognized histopathological 
scoring systems to reveal its validity and accuracy. A complete and extensive 
animal model study was presented in this thesis to demonstrate the ability of 
the SHG/TPEF imaging modality to extract useful information for accurate 
fibrosis assessment. 
With the potential of SHG/TPEF imaging modality’s intrinsic sectioning and 
ability to extract tissue information from unstained tissue samples, we later 
proposed using this imaging modality for high-resolution fibrosis scanning on 
intact tissue. Due to the opaque nature of the liver organ, such scanning was 
restricted to the surface of the organ. Therefore, the relationship between the 
liver surface and the whole liver organ was studied to explore the possibility 
of assessing liver fibrosis based on liver surface information extracted. As the 
 3 
qualitative indication of capsule thickening in rats was suggested before [14], 
the features of both capsule and sub-capsule regions were investigated. Quan-
titative comparison between these features in liver surface and liver interior 
were shown and further compared with histopathological findings. 
With the discovery of strong correlation between fibrosis distribution on liver 
surface and in liver interior in a later chapter, we envisioned surface quantifi-
cation of liver fibrosis progression through laparoscopy application. To test 
the feasibility of such approach on animal models without the currently avail-
able SHG/TPEF laparoscopy device, we proposed establishing an animal 
model for in vivo imaging through installing an intravital window chamber on 
the rat abdomen. This lead to the discovery and refinement of materials and 
designs for the intravital chamber device as well as the imaging stage that ac-
commodates the live animal imaging on the current microscope setup. Live 
imaging of rat liver was successfully performed on such a stage. A different 
animal model was also explored in this study to adapt to the intravital window 
chamber for better imaging quality. 
To provide a background and rationale for the thesis studies, a literature re-
view is presented in the following chapter. The cause of liver fibrosis and its 
pathogenesis is briefly introduced, followed by the current diagnostic methods 
and problems in diagnosing of the disease. Imaging methods that would be 
employed in the thesis studies are also described and explained in the chapter. 
The chapter ends with the potential application of the imaging modalities in 
the biological study, especially in the liver fibrosis investigation, which leads 
to the three specific aims of this thesis, presented in Chapter 3. Chapter 4 de-
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scribed the establishment of a quantification system for liver fibrosis that 
based on the imaging modalities, which lays out the foundation for future liver 
fibrosis surface assessment in Chapter 5 and the intravital window model for 
live imaging and live fibrosis surface exploration in Chapter 6. Chapter 7 con-
cludes all the major findings of the studies and the implications. Chapter 8 
ends the thesis with recommendation for future studies. 
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Chapter 2 Background and Significance 
This chapter presents background information that defines the rationale for the 
thesis research. Section 2.1 is the brief review of liver fibrosis disease, which 
we break down into three parts. Part 1 is the introduction of liver as a func-
tional organ and the disease in liver that we are going to focus on studying, 
which is liver fibrosis. Part 2 continues on the detailed description of the cause 
and pathogenesis of liver fibrosis, which leads to part 3, the diagnosis and the 
current problems we face in diagnosing liver fibrosis. To help solving the di-
agnostic difficulties in liver fibrosis, we introduce imaging based methods, 
which we describe in detail in Section 2.2. This section is also broken down 
into two parts, with first part describing the theory and advantages of SHG and 
TPEF two imaging modalities we are going to use, and second part focusing 
on the application of these two imaging modalities in biological studies. 
 6 
2.1 Pathogenesis and diagnosis of liver fibrosis 
2.1.1 Liver and liver fibrosis 
Liver is one of the largest organs in the adult body and mainly consists of two 
lobes. It is a vital organ with a wide range of functions, such as detoxification, 
protein synthesis, and production of biochemicals necessary for digestion. 
This organ plays a vital role in metabolism and has a number of functions in 
the body, including glycogen storage, decomposition of red blood cells, plas-
ma protein synthesis, hormone production, and detoxification. It produces bile, 
an alkaline compound which aids in digestion. It also performs and regulates a 
wide variety of high-volume biochemical reactions requiring highly special-
ized tissues, including the synthesis and breakdown of small and complex 
molecules, which are necessary for normal vital functions [15]. 
To look at the architecture of the liver, it lies in the abdominal cavity, in con-
tact with diaphragm. The mass is divided into several lobes, of which the 
number and size vary among species. The image below (Figure 1(a)) is of a 
liver from a fibrotic rat, and shows that aspect of the liver that faces the con-
tents of the abdominal cavity. Liver is covered with a connective tissue cap-
sule that branches and extends throughout the substance of the liver. The con-
nective tissue tree provides a scaffolding of support and helps with the blood 
vessels, lymphatic vessels and bile ducts traverse the liver. The sheets of con-
nective tissue also divide the parenchyma of the liver into very small units 
called lobules (Figure 1(b)), the structural unit of the liver. It consists of 
roughly hexagonal arrangement of plates of hepatocytes radiating outward 
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from a central vein in the center. Portal triads are distributed at the vertices of 
the lobule [16]. 
 
Figure 1. Liver anatomy and the structure of the hepatic parenchyma. (a) Formalin 
fixed liver from a fibrotic rat. (b) Tissue structure of standard liver tissue, with lob-
ules as the structure unit of the liver. 
Liver fibrosis is the growth of scar tissue due to infection, inflammation, inju-
ry, or even healing. It results from chronic damage to the liver in conjunction 
with accumulated deposition of ECM proteins, a characteristic of most types 
of chronic liver diseases. Accumulation of ECM proteins distorts the hepatic 
architecture by forming a fibrous scar. Subsequent development of nodules of 
regenerating hepatocytes defines cirrhosis, which produces hepatocellular dys-
function and increased intrahepatic resistance to blood flow. These result in 
hepatic insufficiency and portal hypertension, respectively [17]. 
The onset of liver fibrosis is usually insidious, and most of the related morbid-
ity and mortality occur after the development of the disease into late stage, 
which is cirrhosis [18]. Progression to cirrhosis normally occurs after an inter-
val of 15-20 years for majority of patients. Clinical complications of cirrhosis 
include ascites, renal failure, hepatic encephalopathy, and variceal bleeding. 
 8 
For most patients, cirrhosis is associated with short survival, and liver trans-
plantation is often indicated as the only effective therapy [19]. Patients with 
cirrhosis are also at much higher risk of developing hepatocellular carcinoma. 
Currently, cirrhosis and hepatocellular carcinoma are among the top ten causes 
of death worldwide, and in many developed countries liver disease is now one 
of the top five causes of death in middle-age group [20, 21]. Liver fibrosis can 
progress rapidly to cirrhosis in several clinical settings, such as repeated epi-
sodes of severe acute alcoholic hepatitis, subfulminant hepatitis, and fibrosing 
cholestasis with Hepatitis C Virus (HCV) reinfection after liver transplantation 
[22]. The causal and natural history of liver fibrosis is influenced by genetic as 
well as environmental factors [23] (Table 1). 
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Table 1. Genetic and nongenetic factors associated with fibrosis progression in differ-
ent types of chronic liver diseases 






 Angiotensinogen Coinfection HIV and/or 
hepatitis B virus 
 Transforming growth factor 
β1 
Age at time of acute infection 
 Tumor necrosis factor α Liver transplantation 
 Apolipoprotein E Diabetes mellitus 
 Microsomal epoxide hy-
droxylase 
No response to therapy 
 Monocyte chemotactic pro-
tein type 1 and type 2 
 
 Factor V (Leiden)  
Alcohol induced Interleukin 10 Alcohol intake 
 Interleukin 1β Episodes of alcoholic hepati-
tis 
 Alcohol dehydrogenase  
 Aldehype dehydrogenase  
 Tumor necrosis factor α  
 Transport-associated anti-





 Angiotensinogen Severity of obesity 
 Transforming growth factor 
β1 
Diabetes mellitus 
  Hypertriglyceridemia 
PBC Interleukin 1β  
 Tumor necrosis factor α  
 Apolipoprotein E  
Autoimmune hepatitis Human leukocyte antigen 
type II hyptotypes 
Type II autoimmune hepatitis 
  No response to therapy 
 
2.1.2 Pathogenesis of liver fibrosis 
Liver fibrosis results from wound-healing response to repeated liver injury 
[24]. Once acute liver injury occurs, parenchymal cells regenerate and replace 
the necrotic or apoptotic cells. Inflammatory response comes with this pro-
cess, together with limited deposition of ECM. If the hepatic injury persists, 
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eventually the liver’s regeneration function would fail, and hepatocytes are 
substituted with abundant ECM, especially fibrillar collagen. Distribution of 
such fibrous material is dependant on the location of the onset of the liver in-
jury. For chronic viral infection and chronic cholestatic disorders, fibrotic tis-
sue is initially located around portal tracts, while in alcohol and drug-induced 
liver disease, it locates in pericentral and perisinusoidal areas [25]. With the 
progression of the fibrotic liver disease, the collagen forms bridging fibrosis 
and frank cirrhosis occurs. 
Development of liver fibrosis features in major alterations in both quantity and 
deposition of hepatic ECM. Activated hepatic stellate cells (HSC) are believed 
to be the major producers of the fibrotic neomatrix [12, 26]. In normal liver, 
hepatic stellate cells reside in the space of Disse and are the major storage 
sites of vitamin A, stored in the cytoplasm as retinyl esters. Following chronic 
liver injury, HSCs undergo morphological and functional changes, proliferate 
and activate or transdifferentiate into smooth muscle α–actin positive myofi-
broblast-like cells (activated HSC), acquiring contractile, proinflammatory and 
fibrogenic properties, meanwhile lose their vitamin A storage [27, 28]. Anoth-
er endogenous liver cell type that is implicated in hepatic fibrogenesis is the 
portal fibroblast, which is derived from small portal vessels [29]. However, 
they proliferate more slowly than activated HSCs and would only be activated 
during portal injury [30]. Therefore, they have smaller contribution to liver 
fibrosis than HSCs. Circulating fibrocytes [31], bone marrow [32] and Epithe-
lial-Mesenchymal Transition (EMT) [33] would also contribute to the myofi-
broblasts formation and fibrosis progression. However, the relative contribu-
tion of each source varies among different etiologies (Figure 2). 
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Figure 2. Contributions of activated stellate cells and other fibrogenic cell types to 
hepatic fibrosis. Quiescent stellate cell activation is initiated initially by a range of 
soluble mediators, and further by key cytokines into myofibroblasts (which contain 
contractile filaments). Over time, however, other sources also contribute to fibrogenic 
populations in liver, including bone marrow (which likely gives rise to circulating 
fibrocytes), portal fibroblasts, and epithelial mesenchymal transition from hepato-
cytes and cholangiocytes. Relative contributions and the stages at which these cell 
types add to the myofibroblast population is likely to differ among various etiologies 
of liver injury. 
Activated HSCs migrate and accumulate at the tissue reparing sites, produce a 
wide variety of collagenous and non-collagenous ECM proteins and regulate 
ECM degradation. Collagen synthesis in HSCs in fibrotic liver tissue is regu-
lated at both transcriptional and posttranscriptional levels [34]. Over time, 
subendothelial matrix composition changes into one rich in fibril-forming col-
lagens. These progressive changes in matrix composition due to fibrosis ac-
cumulation also trigger several positive feedback pathways that further ampli-
fy fibrosis. These include the stellate cell activation and migration by mem-
brane receptors signaling [35], release of growth factors to stimulate fibrogen-











lus to stellate cell activation by matrix stifferning due to the enhanced density 
of ECM [38]. Due to these factors, in advanced stages, liver contains approx-
imately six times more ECM overall than normal liver, and there is increasing 
deposition of collagen types I and IV, undulin, elastin and laminin. Although 
collagen types I, III and IV are all increased, type I increases most and its ratio 
to types III and IV also increases [39-42]. Also, as the prototype constituent of 
the fibril-forming matrix in fibrotic liver, collagen type I degradation is being 
particularly important for recovery of normal liver histology [43]. 
2.1.3 Diagnosis of liver fibrosis 
The stage of liver fibrosis is a measure of how far it has progressed in its natu-
ral history, with end stage resulting in cirrhosis with clinical decompensation 
or liver organ failure. The grade of liver fibrosis is meant to reflect how quick-
ly fibrosis is progressing to the end stage. Evaluation of fibrosis stage over 
time can determine the disease progression, response to therapy and optimiza-
tion of treatment. Ability to identify the occult advanced fibrosis may also di-
rect further management [44]. 
Currently, liver biopsy is still considered the gold-standard method for the di-
agnosis and assessment of liver fibrosis. Histological examination is per-
formed to identify the underlying cause of liver disease and assessing grade 
and stage of fibrosis, usually scaled as Metavir (stage 0-4) [45] and Ishak 
score (stage 0-6) [46], with progression in stage advances from none to fibrous 
portal expansion to bridging fibrosis to incomplete cirrhosis and finally to es-
tablished cirrhosis. Numerical numbers are assigned to correspond to these 
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stages (Table 2). Specific staining of ECM proteins (with Sirius red or Mas-
son’s trichrome) is used for such histological grading. As an invasive proce-
dure, liver biopsy comes with pain and major complications occurring in 40% 
and 0.5% of patients, respectively [47]. Since needle liver biopsy only re-
moves 1/50000 of the total organ, sampling error can occur, and it will affect 
the extent to which grading and staging can be accurately performed. Study 
has shown that cirrhosis is missed on single blind liver biopsy in between 10% 
and 30% of cases [48-50]. Studies have suggested that an adequate biopsy 
sample should be 15mm long at least and have more than 5 portal tracts [51, 
52]. When many good quality biopsies are evaluated, however, as in laborato-
ry study or in clinical trial, a great degree of accuracy can be achieved [46]. 
Also, inter- and interaobserver variability in the interpretation of the needle 
biopsy results is well know to occur, and histological examination does not 
predict disease progression [6]. 
Table 2. Grading and staging systems for chronic liver fibrosis using different scoring 
systems. 
stage Metavir Ishak score 
0 No fibrosis No fibrosis 
1 Fibrous portal ex-
pansion 
Fibrous expansion of some portal areas, with 
or without short fibrous septa 
2 Few bridges or sep-
ta 
Fibrous expansion of most portal areas, with 
or without short fibrous septa 
3 Numerous bridges 
or septa 
Fibrous expansion of most portal areas with 
occasional portal to portal bridging 
4 Cirrhosis Fibrous expansion of most portal areas with 
marked bridging (portal to portal as well as 
portal to central) 
5  Marked bridging (portal-portal and/or portal-
central) with occasional nodules (incomplete 
cirrhosis) 
6  Cirrhosis, probable or definite 
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Besides liver needle biopsy, a large number of putative serum markers are also 
evaluated for the assessment of hepatic fibrosis. Scores that include routine 
laboratory tests, such as platelet count, aminotransferase serum levels, pro-
thrombin time, and acute phase proteins serum levels are proposed [53, 54]. 
Other serum levels of proteins that directly related to hepatic fibrogenic pro-
cess are also used [55]. These scores are useful for detecting advanced fibrosis 
as well as no fibrosis, however, when it comes to intermediate grades, these 
scores are not very accurate. Meanwhile, all the fibrosis-specific markers in 
the blood may reflect fibrogenesis in other organs and would be affected by 
changes in their metabolism. Therefore, unless ideal features [56] (Table 3) of 
fibrosis markers can be met, biopsy still lies in as the best way for diagnosis. 
Table 3. Ideal features of a fibrosis biomarker  
Liver specific 
Independent of metabolic alterations in liver, renal, or reticuloendothelial function 
Easy to perform 
Minimally altered by urinary or biliary excretion 
Reflective of fibrosis from any chronic liver injury 
Sensitive to discriminate between different stages of fibrosis 
Ability to correlate with dynamic changes in fibrosis progression or regression 
Ability to predict clinical outcomes including liver failure and mortality 
 
Other non-invasive diagnostic tools include ultrasonographic and tomographic 
evaluation of the liver. Transient elastography (FibroScan) is rapid bedside 
method for assessing liver fibrosis by measuring liver stiffness, and recent 
studies suggest that it has the potential to detect significant fibrosis [57]. How-
ever, inherent limitation of this technique is that it may not give accurate re-
sults in obese patients, as the depth of the signal penetration is limited. Also, 
stiffness of liver is changing with age, so better standardization will be re-
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quired for large scale application. Other study also shows that transient elas-
tography is biased when patients is undergoing acute liver damage [58]. Mag-
netic resonance spectroscopy (MRS) has drawn growing interest in potential 
role for detecting fibrosis, however, currently most studies used small number 
of samples, and therefore needs to be confirmed in larger studies with stand-
ardized methods [59]. Magnetic resonance elastography (MRE) is currently 
being evaluated for diagnosis purpose, however, albeit with the encouraging 
initial data, high negative predictive value may only allow it to be used for pa-
tients who are under consideration for biopsy to assess possible hepatic fibro-
sis [60]. MRS and MRE also both need special room to perform the procedure 
and highly dependent on operator expertise. In all, although current non-
invasive imaging methods have less sampling errors as biopsy, these methods 
still have their drawbacks, and therefore, cannot be used routinely and obviate 
the need for liver biopsy. 
Since liver biopsy still remains the only reliable method for assessment of fi-
brosis, most therapeutic approaches discovered in rodents [61] to prevent fi-
brosis progression have not been proven in human due to the need to perform 
serial liver biopsies to accurately determine the changes in fibrosis, and the 
necessity of long-term follow-up studies. Therefore, in the long run, the avail-
ability of reliable non-invasive or minimum-invasive markers of liver fibrosis 
should have a remarkable impact on the design of clinical trials as well as live 
animal studies, and that would also benefit patients with chronic liver disease 
who need long term follow up. 
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2.2 Imaging modality SHG and TPEF 
2.2.1 Theory and advantages of SHG and TPEF 
There are a number of notable nonlinear optical techniques, including multi-
photon excited fluorescence [62], higher harmonic generation [63, 64] and 
Raman scattering [65]. All of them are nonlinear responses of the material to 
high power light excitations. Even though the physical origin of each phenom-
enon is starkly different, comparison of these techniques are derived according 
to their sensitivity and selectivity. 
In terms of sensitivity, multi-photon excited fluorescence has the potential for 
single molecule detection whereas higher harmonics require 104 to 106 mole-
cules for their detection. This limits higher harmonics applications in the de-
tection of one or a small number of molecules. On the other hand, coherent 
anti-stokes and stimulated Raman scattering [66] provide an unprecedented 
means of chemical selectivity which is intrinsic to the molecules within cells 
and tissues as the vibrational bands of each kind of molecule serves as a spec-
tral signature which can be utilized as a contrast mechanism for imaging. In 
addition to vibrational spectroscopic methods, higher harmonics can differen-
tiate molecular orientation and show specificity for membranes. 
The macroscopic polarization is proportional to the electric field strength in 
the regime of linear optics. P = χ(1) ε0 E where ε0 is the relative permittivity of 
free space and χ(1) is the linear susceptibility of the medium independent of the 
field. As the electric field strength becomes comparable to the intra-atomic 
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electric field, as in the case of laser radiation, the response becomes nonlinear. 
Since nonlinear response usually manifests itself as small deviations from lin-
ear response, a power series expansion in the field is used, P = χ(1)E + χ(2)EE 
+ χ(3)EEE + … where the susceptibilities χ(1),χ(2) and χ(3) are tensors of se-
cond, third and fourth ranks respectively. 
Almost all optical phenomena are described by the first three terms in the 
equation. The linear term involving χ(1) gives rise to the index of refraction, 
absorption, dispersion and birefringence of the medium. Most of the interest-
ing nonlinear optical effects arise from the terms of electric polarization, 
which are quadratic or cubic in the electric field. The quadratic polarization 
gives rise to the phenomena of second harmonic generation, sum- and differ-
ence- frequency mixing, and parametric generation, while the cubic term is 
responsible for third-harmonic generation, two-photon absorption, stimulated 
Raman scattering, optical bistability and phase conjugation. 
Fluorescence is the optical relaxation phenomenon whereby light emission 
occurs in the time scale of nanoseconds after excitation from singlet ground 
state to singlet excited state. The energy of the emitted photon on relaxation 
corresponds to the difference in energy of the lowest vibrational level of the 
excited state and the vibrational level of the singlet ground state. Maria Göp-
pert-Mayer made the first prediction of the possibility of multiphoton excita-
tion in her doctoral thesis in 1931 [67] which was not experimentally realized 
until 1961 by Kaiser and Garret [68] following the development of lasers. In 
conventional one-photon absorption, excitation occurs when the photon ener-
gy absorbed matches the energy difference between the ground and excited 
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states. Two less energetic photons can be simultaneously absorbed for the 
same transition. The basic principle of TPEF is shown schematically in Figure 
3.  
 
Figure 3. Jablonski diagram of the Two Photon Excitation Fluorescence (TPEF) and 
Second Harmonic Generation (SHG) process. 
The interaction between the fluorophore and excitation electromagnetic field 
are solutions to time-dependent Schrödinger equation through perturbation 
theory where the Hamiltonian contains an electric dipole interaction term: Eγ⋅r 
where Eγ is the electric field vector of the photons and r is the position opera-
tor. The nth-order solution corresponds to n-photon excitation with transition 
probability, P and, for the two-photon excitation process, P(2) is given by [69] 
 where εγ is the photonic energy associated to 
the electric field Eγ , f, i and m are the final initial and intermediate states re-














The transition rate, R(2) is the time derivative of the transition probability as 
 where σ(2) is the cross-section for the two-photon ab-
sorption process and I the intensity of the electromagnetic field. This two-
photon absorption rate is proportional to the imaginary part of the third-order 
nonlinear optical susceptibility. The selection rules for transitions between fi-
nal and excited states are symmetry and parity dependent which is the result of 
group theoretic and spin considerations of the system respectively. In two-
photon processes, a transition between states of the same parity is allowed as a 
result of two dipole terms in P(2), unlike the case for one-photon transitions 
where it is forbidden. 
We next divert our discussion towards the theory of second harmonic genera-
tion (SHG). We begin from Maxwell’s wave equation for a non-absorbing, 
non-conducting dielectric medium containing no free charges [70], the dia-
gram of SHG process is shown in Figure 2.   
where E is the electric field vector of the electromagnetic field and PNL is the 
polarization vector containing higher order susceptibilities of the medium. 
Since we are interested in second order nonlinear effects, we can ignore higher 
order terms than χ2 and assume that the electromagnetic waves are plane 
waves propagating in the z direction. We simplify our analysis by considering 
a total field E consisting of three infinite uniform plane waves ignoring the 
effects of double refraction and focusing. The total instantaneous field is 
therefore of the form  where 
j = 1, 2, with ω1 = ω and ω2 = 2ω, Ej is the complex amplitude of field j, Aj 
R 2( ) = ddt P









E j (z,t) = E j (z)e"i# j t + c.c. = A j (z)ei(k j z"# j t ) + c.c
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represents the spatially slowly varying field amplitude and c.c. means complex 
conjugate.  where P2 represents the complex am-
plitude of the nonlinear polarization. If these expressions are introduced to the 
above wave equation and utilizing the slowly varying amplitude approxima-
tion, we obtain  Upon direct integration, assuming 
A1 to be constant, we find the amplitude of the second harmonic field after 
propagation through a distance L to be given by  
where . The intensity of the generated radiation is thus 
 Only those interactions for 
which Δk = 0 will undergo macroscopic amplification as they propagate 
through the medium. Nevertheless, even though the second order nonlinear 
susceptibility, χ(2), is non-zero in non-centrosymmetric media, nonlinear emis-
sion dipoles aligned in an anti-parallel arrangement which produce SHG ex-
actly out of phase, may result in the cancellation of the signals due to destruc-
tive interference. 
2.2.2 Application of SHG and TPEF in biological study 
Nonlinear microscopy with its distinct advantages for 3D imaging is consid-
ered to be an alternative to conventional confocal microscopy for the imaging 
of biological samples. Two-photon excitation fluorescence (TPEF) microsco-
py can provide optical sectioning without absorption above and below the 
plane of focus, thus greatly reducing photobleaching and phototoxicity, com-
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pared to confocal microscopy. In addition, the penetration depth is increased 
many times up to a few hundreds microns [71]. Nowadays, this technique is 
used for imaging electrical activity in deep tissue, such as mapping network 
organization of neuronal electrical activity [72, 73] and the 3D blood flow ar-
chitecture in the brain [74]; Quantitative imaging of immune-cell motility and 
morphology, such as the in vivo interaction of T cells and dendritic cells (DCs) 
dynamics in lymph nodes [75], in cranial bone marrow [76] and in tumors 
[77]; imaging structure and function of cancer, such as studying gene expres-
sion and physiological function in the deep internal regions of tumors [78].  
Another important nonlinear microscopy recently widely used in life science 
research is second harmonic generation microscopy (SHG). Compared to con-
ventional fluorescence imaging, SHG exhibits intrinsic advantages, as the pro-
cess requires no fluorophore presence in tissue; thus, signals are unaffected by 
dye concentration and photobleaching. Besides, the excitation source can be in 
the infrared range, resulting in less scattering in tissues than that in the visible 
wavelength range and deeper tissue penetration for imaging purposes. Two 
main areas of research in SHG imaging over the past few years have been 
measuring neurons and collagen, which have special structural properties [79, 
80]. In particular, SHG can be used for quantitative measurement of collagen 
in various organs as an indication of fibrosis development [13, 79, 81], espe-
cially for detect fibrosis in livers [82]. 
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2.2.3 Image processing techniques in extracting SHG/TPEF signals 
To extract useful information from digitized SHG/TPEF images, and to further 
study and quantify such information, image processing techniques are em-
ployed after images are acquired. Current state-of-the-art image processing 
techniques include: Histogram thresholding, region based approaches, edge 
detection, Fuzzy techniques and Neural Network approaches. 
Histogram thresholding is one of the most commonly used techniques in im-
age processing. It can be done based on global information, the gray level his-
togram of the entire image, or, it can be done using local information, gray 
levels of the sub-regions that are partitioned from the whole image. This is 
also known as adaptive thresholding [83-85]. Thresholding can also be classi-
fied into bilevel and multi-thresholding. In bilevel thresholding, the image is 
partitioned into two regions: object (black) and background (white), whilst in 
multithresholding, the image is separated into several objects based on surface 
characteristics with multiple thresholds for segmentation. If the image is com-
posed of regions with different gray level ranges, the histogram of the image 
usually shows different peaks, with each corresponding to one region and ad-
jacent peaks separated by a valley. There are various thresholding methods 
available for this. Commonly used ones include Otsu, which maximizes the 
ratio of the between class variance (or minimize the intra-class variance) to the 
local variance to obtain thresholds [86]. 
Region based approaches attempt to group pixels into homogeneous regions, 
and include region growing, region splitting, region merging and their combi-
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nations [87, 88]. It works best on images with an obvious homogeneity criteri-
on and tend to be less sensitive to noise. In general, it is preferred for color 
image segmentation. In region growing approach, a seed region is selected and 
then expanded to include all the homogeneous neighbors until all pixels in the 
image are classified. Problem with this approach is the inherent dependence 
on the seed region selection as well as the order in which pixels and regions 
are examined. In region slitting approach, the whole image is regarded as ini-
tial seed region. If seed region is not homogenous, it is then divided into four 
squared sub-regions as the new seed regions. The process is repeated until all 
sub-regions are homogenous. The disadvantage of this approach is the tenden-
cy of the results mimicking the data structure, the square shape. The region 
merging approach is frequently combined with region growing and region 
splitting approach to merge the similar regions into larger homogeneous re-
gions. It suffers the same drawbacks as the previous two methods. 
Edge detection is based on detection of discontinuity in gray level, which lo-
cates points of abrupt changes in gray level intensity values. Techniques in 
edge detection are usually classified into two categories: sequential and paral-
lel [89, 90]. Sequential edge detection means the decision whether a pixel is an 
edge pixel or not is dependent on the result of the previously examined pixels. 
The performance of a sequential edge detection method is dependent on the 
choice of an appropriate starting point and how the results of the previous 
points affect the choice and result of the next point. The existing techniques 
mainly utilize heuristic search and dynamic programming. Parallel edge detec-
tion means the decision whether a point is an edge is made based on the point 
under consideration and its neighboring points. Therefore, this method can be 
 24 
applied to every point in the image simultaneously. One technique in perform-
ing parallel edge detection is high-emphasis spatial frequency filtering. Since 
high spatial frequencies are associated with sharp changes in intensity, Fourier 
operator can be used to perform high-pass filtering to extract edges. The ques-
tion lies in how to design a relevant filter. 
The image processing techniques mentioned above are all based on crisp deci-
sions about regions. However, regions in an image are not always crisply de-
fined, and uncertainty occurs at each level of image analysis and pattern 
recognition. Fuzzy techniques provide a mechanism to represent and manipu-
late uncertainty and ambiguity [89, 91]. In fuzzy subsets, each pixel in an im-
age has a degree to which it belongs to a region, characterized by a member-
ship value. By doing so, information can be kept through the higher pro-
cessing levels. Fuzzy-C means (FCM) clustering algorithm [92] has been 
widely used in image segmentation. It is an iterative optimization method, 
which calculates the memberships of a data point in each of the clusters based 
on the distances between the point and the cluster centers. The cluster centers 
are then updated to reflect the resulting clusters. An objective criterion func-
tion is used in the iteration to minimize the distance between data point in a 
cluster and the cluster center, and to maximize the distance tween between 
cluster centers. The cluster centers are then updated to reflect the resulting 
clusters. An objective criterion function is used in the iteration to minimize the 
distance between data point in a cluster and the cluster center, and to maxim-
ize the distance tween between cluster centers. The algorithm minimizes intra-
cluster variance as well, but the minimum is a local minimum, and the results 
depend on the initial choice of weights. 
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Neural networks based approaches [93, 94] are attempted to achieve the goal 
of robust segmentation of the system with respect to random noises, able to 
emulate some aspects of the human information processing system and have 
output in real time. Neural networks are composed of many computational el-
ements connected by links with variable weights. The massive connectionist 
architecture makes the system robust while the parallel processing enables the 
system to produce output in a real time fashion. The complete network repre-
sents a very complex set of interdependencies, which allow very general func-
tions to be modeled. Training time is usually very long, but after training, the 
classification using neural network is rapid. Overtraining should also be 
avoided and the initialization of the training set may also affect the results. 
In general, the selection of an appropriate image processing method or algo-
rithm mainly depends on the type of images and application areas. In this the-
sis, we have explored a few methods for our fibrosis quantification purpose. 
2.3 Significance of using SHG/TPEF in liver fibrosis study 
Since percutaneous liver biopsy still represents the gold standard in liver fi-
brosis diagnosis and assessment, to specifically and accurately monitors liver 
fibrosis in a quantitative manner, information extracted has to be directly 
compared to morphological features recognized by the histological examina-
tion of the liver biopsy samples. So far, putative serum markers have been 
tested to detect such changes, however, due to the nonspecificity nature of the 
markers, changes in them cannot be exclusively attributed to liver fibrosis. 
Non-invasive imaging methods have also been employed to explore the liver 
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changes, such as ultrasonography, transient elastography, and magnetic reso-
nance elastography; however, they are based on liver stiffness measurement 
(LSM) rather than the histological changes. Thus, their sensitivity is less satis-
factory and comparability to gold standard liver biopsy is low. 
In light of the current limitations to liver fibrosis assessment and the advances 
of the state-of-art imaging modality SHG/TPEF, we are proposing in this the-
sis to use SHG/TPEF as an imaging tool to study liver fibrosis. Since the mor-
phological features of hepatocytes can be detected by TPEF signals while col-
lagen deposition, the vital indicator of liver fibrosis, can be monitored by the 
increase of SHG signals, images generated by SHG/TPEF can be used as a 
direct comparison to histopathological examinations with the advantage of not 
using dyes in imaging and less time required for data collection. With the right 
techniques in image processing, data collected from SHG/TPEF can be used 
for quantitative assessment of liver fibrosis. 
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Chapter 3 Objective and Specific Aims 
This thesis aims to develop a novel detection and diagnostic method for liver 
fibrosis progression based on non-linear optical microscopy. To achieve this 
goal, three steps were taken, which formed the three specific aims in this the-
sis. Each aim solves a single scientific problem and constitutes a single chap-
ter following Chapter 3 in this thesis to elaborate the studies and findings re-
spectively. 
Specific Aim One: To establish and modify a quantification system for 
liver fibrosis. 
Hypothesis 1: Type I Collagen, which can be detected by SHG, as the most 
abundant collagen of mature scar tissue present in portal fields and fibrous 
septa, can be used as a quantitative measurement of liver fibrosis. Liver tissue 
morphology extracted by autofluorescence of liver cells can be quantified to 
reveal the important indication of fibrosis progression. 
Specific Aim Two: To quantify liver fibrosis based on the information on 
and near liver surface 
Hypothesis 2: The degree of liver fibrosis across the liver surface can be used 
as an indication of the fibrosis within the whole organ. Extracted information 
through SHG and TPEF imaging modalities within certain depth from liver 
surface alone will be enough to stage liver fibrosis progression. 
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Specific Aim Three: To modify and stabilize an intravital window based 
imaging chamber in live animal for investigation of fibrogenesis and de-
tection of liver fibrosis in vivo. 
Hypothesis 3: Fibrogenesis in liver can be better studied by visually detecting 
the fibrosis progression pattern in live animals. By live imaging the liver sur-
face through a window based chamber with enough penetration depth, the fi-
brosis across the whole liver can be understood accurately. 
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Chapter 4 Establish and Modify a Quantification System for Liver 
Fibrosis 
4.1 Introduction 
Liver fibrosis, as a common pathway leading to cirrhosis, the end result of in-
jury of the liver, is becoming an increasing concern worldwide, with most oc-
currences in Asia Pacific as a consequence of acquiring hepatitis viruses. Ac-
curate assessment of the degree of fibrosis is important for both clinical treat-
ment and laboratory studies. With the evolvement of current fibrosis treat-
ment, which aims at reversing fibrosis, such precise assessment is becoming 
more demanded for therapeutic efficacy evaluation [45, 95, 96]. Liver biopsy 
is considering the “gold standard” to assess fibrosis, however, its semi-
quantitative analysis based on histological staining suffers many drawbacks, 
such as limited sensitivity, accuracy and operator-dependent variations [46, 
97]. Also, such results are highly subjected to interpretations by the observers 
[98-102]. It is reported that the intra- and interobserver discrepancy is as high 
as 35% in the assessment of liver fibrosis [98, 103-106] despite efforts to im-
prove diagnostic accuracy for qualitative scoring systems [46, 95]. Other mor-
phometric quantification systems such as FibroXact, FibroQuant, Bioquant 
Nova Prime have been reported to achieve a continuum in fibrosis quantifica-
tion based on automated color segmentation [101, 107-110]. However, the 
common difficulty faced by those procedures is the variation in the staining 
process resulting from different batches of stains, protocols, time-dependent 
fading and photobleaching. 
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Over the past decades, second harmonic generation (SHG) microscopy and 
two-photon excitation fluorescence (TPEF) have been increasingly used in 
biological science research. Since SHG is a nonlinear optical process, it exhib-
its intrinsic advantages over conventional fluorescence imaging by requiring 
no fluorescent molecules in the tissue to generate signals and minimum photo-
bleaching. Longer wavelength excitation sources such as infrared range are 
often used for SHG, therefore, deeper tissue penetration and less scattering in 
tissues can be achieved [111-117]. Since SHG microscopy is sensitive to high-
ly ordered structures without central symmetry in tissue, such as type I colla-
gen [13, 81], it has been used for quantitative measurement of collagen in var-
ious organs as an indication of fibrosis development [13, 118]. The feasibility 
of using SHG microscopy in observing fibrosis in liver has also been demon-
strated [82, 119]. Our group has developed a SHG based imaging system for 
highly sensitive collagen detection. The signals detected are standardized and 
highly reproducible. 
In this study, we first developed a comprehensive animal liver fibrosis model 
of different severity level. After unsuccessful screening of mutant Zebrafish 
that are susceptible to liver damage, we established a rat fibrotic model that is 
comparable to human Primary Biliary Cirrhosis (PBC) and Biliary atresia 
(BA) using Bile Duct Ligation (BDL) surgery. Then combining TPEF and 
SHG microscopes, we systematically developed an automated morphology-
based quantification system to assess the fibrosis progression. We extracted 
and validated such morphological features during fibrogenesis by comparing 
the images from SHG/TPEF with images from Masson’s trichrome-stained 
images, with the help from a pathologist. Such quantification results are also 
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validated by comparing scores with the existing gold standard for liver fibrosis 
diagnosis: qualitative morphological staging performed by pathologists. Our 
results confirm that our quantification system can sensitively identify morpho-
logical features from liver tissues, and the general trend of all the features we 
identified are consistent with the pathogenesis of liver fibrosis. Using our im-
aging modality for quantification of liver fibrosis therefore can automate the 
diagnosis of liver fibrosis with high accuracy and also significantly reduce the 
time required for diagnosis by removing the tissue staining process and elimi-
nating inter- and intraobserver discrepancies. 
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4.2 Materials and Methods 
4.2.1 Zebrafish housing and mutagenesis 
Male Zebrafish were mutagenized by treatments with 3.0mM N-ethyl-N-
nitrosourea (ENU) as described by literature [120]. Surviving and fertile fish 
were outcrossed with heterozygous albino (alb/+) females to generate F1 
progeny for the library. To generate a library of 1056 mutagenized fish, 
healthy looking F1 males and females were finclipped (tail) and grouped into 
12 fish per tank of 88 pools. To later recover the fish carrying a specific muta-
tion, all 12 fish from apositive pool were finclipped again, housed separately, 
and genotyped. 
4.2.2 Genome DNA isolation and DNA library Construction  
Genomic cDNA for the library was isolated from finclips in 96-well plates for 
the library and single tubes for the genotyping. Freshly cut finclips were trans-
ferred directly to plates/tubes that are kept on dry ice. Fins were lysed by 
overnight incubation at 55°C in 400 µL pre-warmed lysis buffer (100 mM 
Tris-HCl at pH 8–8.5, 200 mM NaCl, 0.2% SDS, 5 mM EDTA, and 100 
µg/mL proteinase K). DNA was precipitated by adding 300 µL of isopropanol 
and centrifugation at >6000g, and washed using 70% ethanol. Pellets later 
were dissolved in 1mL of water. For the DNA library, 5-µL aliquots were ar-
rayed in 96-well PCR plates, covered with aluminum foil tape and stored at -
20°C. 
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4.2.3 Polymerase Chain Reaction (PCR) of mutant gene 
Target gene hepatocyte growth factor-like (hgf-like) is amplied by a nested 
PCR approach. In the first PCR with three gene specific primers, a touchdown 
cycling program was used (94°C for 60 sec; 30 cycles of 94°C for 20 sec, 
65°C for 30 sec with a decrement of 0.5°C per cycle, and 72°C for 60 sec; fol-
lowed by 10 cycles of 94°C for 20 sec, 58°C for 30 sec, and 72°C for 60 sec, 
and an additional extension step of 72°C for 180 sec). PCR samples contained 
5 µL of genomic DNA isolated from finclips, 0.2 µM forward (f1) and 0.2 µM 
reverse (r1) primer, 200 µM of each dNTP, 25 mM Tricine, 7.0% Glycerol 
(m/v), 1.6% DMSO (m/v), 2 mM MgCl2, 85 mM NH4Acetate (pH8.7), and 
0.2 U Taq DNA polymerase in a total volume of 10 µL.  
After the first PCR reactions, the samples were diluted with 20 µL of water, 
and 1 µL was used as template for the second, nested PCR reaction. This reac-
tion contained a mixture of gene specific forward (0.08 µM) and reverse (0.04 
µM) primers that contain universal M13 adaptor sequences at their 5’ end, and 
the two corresponding universal M13F (0.1 µM) and M13R (0.1 µM) primers 
labeled with fluorescent dyes for detection. In addition, the PCR samples con-
tained 200 µM of each dNTP, 20 mM Tris-Hcl (pH8.4), 50 mM KCl, 1.5 mM 
MgCl2, and 0.1 U Taq DNA polymerase in a total volume of 5 µL. Standard 
cycling conditions were used for the nested PCR reactions (30 cycles of 94°C 
for 20 sec, 58°C for 30 sec, and 72°C for 60 sec, followed by an additional 
extension step of 72°C for 180 sec). 
 34 
4.2.4 Mutant Zebrafish screening 
Following the nested PCR, PCR products were diluted with 30 µL of water, 
and 1 µL was used as template for the sequencing reactions. Sequencing reac-
tions contained 0.5 µL of DYEnamic ET Terminator, 3.5 µL of ET Terminator 
dilution buffer, and 0.5 µM of M13F or M13R primer in a total volume of 10 
µL. Cycling conditions were as recommended by the manufacturer. Sequenc-
ing products were purified using Sephadex G50 (superfine coarse) minicol-
umns, and analyzed on a 96-capillary 3730xl DNA analyzer from Applied Bi-
osystems. 
4.2.5 Rat Bile Duct Ligation (BDL) model establishment 
Male Wistar rats at an average weight of 200g were housed two per cage. Six-
teen rats were randomly separated as four groups, representing 4 time points, 
without BDL, and 2, 4, 6 weeks after BDL surgery. Under sterile surgical 
conditions, rats were sedated. Rats are weighted and injected with Ketamine 
(100mg/kg body weight). We allow 10-15 minutes for anesthesia to occur, in-
dicated by the loss of sensory/ reflex response, i.e. non-response to tail pinch-
ing. The abdomen was shaved later. A transverse incision was made on the 
abdomen, exposing the liver. The liver and intestines were gently displaced to 
expose the bile duct, which were ligated at two areas near the porta with non-
absorbable sutures (silk 3.0) and then transected between the two ligation 
points. Abdominal contents then were gently rearranged and the wound closed 
with double layered tissue closure with absorbable sutures (PDS 4.0). Tetracy-
cline HCL was applied on the closure wound and plastered with a water proof-
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ing protection. Four animals were sham operated. The operation was per-
formed on the heating operation table with surgical lamps to prevent heat loss 
during the operation. All animal-related experiments were approved by the 
Institutional Animal Care and Use Committee (IACUC). 
4.2.6 Liver sample extraction from BDL model 
Two, four, six weeks later after BDL surgery, the animals were sacrificed. 
Rats are weighted and injected with Ketamine (100mg/kg body weight). Al-
low 10-15 minutes for anesthesia to occur, indicated by the loss of sensory/ 
reflex response, i.e. non-response to tail pinching, same as when performing 
the BDL surgery. The livers were perfused through portal vein, with perfusion 
pressure controlled by constant gravity. We flushed the rats livers with 1×PBS 
of 200mls per rat, followed by perfusion of fixative containing 4% formalde-
hyde freshly prepared of 300mul per rat. After the perfusion, whole liver or-
gan was harvested and placed in buffered fixative for further slice sample 
preparation. 
4.2.7 Sample preparation 
4.2.7.a Cryosection 
After fixation, liver tissues were rinsed with 1×PBS, and then cryoprotected 
with 20% sucrose in phosphate at 4°C overnight. Transfered the tissue to an 
embedding mold and filled the mold with Optimum Cutting Temperate (OCT) 
compound. Rapidly submerged the mold into isopentane cooled with liquid 
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nitrogen for the material to freeze. After frozen, the whole block was wrapped 
in aluminum foil and stored at -80°C. We cooled the crystat to -20°C before 
moving the tissue block into place, and cut the sections to 50µm thickness. We 
picked each slice up by pressing a glass slide on the tissue, so that it melts and 
adheres. 
4.2.7.b Paraffin embedded section  
After the fixation, liver tissues were dehydrated by first using graded ethanol 
solutions, then graded xylene solutions, then finally liquid paraffin. The grad-
ed solutions gradually expose the sample to changes in hydrophobicity, mini-
mizing damage to cells. After a short time in the liquid paraffin, the tissue was 
placed into a mold with more paraffin. Embedded samples were cut into 50µm 
thick sections using a microtome. After several slices of the paraffin-
embedded tissue have been sectioned, the slices were removed from the blade 
and floated atop a warm water bath to smooth out the sample. The slices were 
teased apart and floated onto a slide. After the slides have dried, they were 
placed in an oven at 40°C to bake overnight. Before imaging, slices were de-
paraffinized in 2-3 changes of xylene, and hydrate in increasing graded etha-
nol solutions. Then rinsed in distilled water. 
4.2.7.c Masson’s Trichrome staining 
After deparaffin of embedding sections, tissue slices were stained first in Wei-
gert’s iron hematoxylin solution for 10 minutes, flowered by rinsing in dis-
tilled water. Then they were stained in Biebrich scarlet-acid fuchsin solution 
for 15 minutes, followed by rinsing. Differentiated the slices later in phos-
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phomolybdic-phosphotungstic acid solution for 10-15 minutes to check 
whether collagen is not red. Counterstain in blue aniline solution was per-
formed for 5 to 10 minutes, followed by differentiating in 1% acetic water for 
3 to 5 minutes. Last, we dehydrated and cleared the stain through 95% ethyl 
alcohol, absolute ethyl alcohol, and xylene, 2 changes each, 2 minutes each. 
Mounted with resinous medium. After the staining, nuclei were stained black, 
muscle, cytoplasm, keratins were stained red and collagens were stained blue 
[121]. 
4.2.7.d Sirius red staining 
After deparaffin and hydrate sections, nuclei were stained with Weigert's 
haematoxylin for 8 minutes, followed by 10 minutes wash in running tap wa-
ter. We stained the slices later in picro-sirius red for one hour, followed by 
washing in two changes of acidified water. We then physically removed most 
of the water from the slides by vigorous shaking and dehydrated in three 
changes of 100% ethanol. Finally, we cleared the slices in xylene and mount 
in a resinous medium. In bright-field microscopy collagen is red on a pale yel-
low background [122, 123]. 
4.2.8 Histopathological scoring of fibrosis samples 
After Masson’s Trichrome and Sirius red staining of each sample, stained tis-
sues were imaged under optical microscope, and each sample was given a nu-
merical score stating the severity of the liver damage. (Both staining were 
provided for each sample to minimize the variation of staging caused by stain-
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ing process.) All animal tissue scoring was performed by a pathologist accord-
ing to Ruwart et al as there was extensive bile duct proliferation noted [124], 
making it the better scoring system compared with others conventionally used. 
4.2.9 Non-linear microscopy 
The non-linear optical microscope was developed based on a confocal imag-
ing system (LSM 510, Carl Zeiss, Heidelberg, Germany) using an external 
tunable mode-locked Ti:Sapphire laser (Mai-Tai broadband, Spectra-Physics). 
The system is shown in Fig. 1, where laser bean was passed through a pulse 
compressor (Femtocontrol, APE GmbH, Berlin, Germany) and an acousto-
optic modulator (AOM) for group velocity dispersion compensation and pow-
er attenuation respectively. The Laser bean was then routed by a dichroic mir-
ror (reflect >700nm, transmit <543nm), through an objective lens (plan-
neofluar, 20X, NA=0.5, Carl Zeiss, Heidelberg, Germany), to the tissue sam-
ple. The average power at the objective lens is ~80mW. TPEF in the epi-
direction generated in tissue was collected by the same objective lens and rec-
orded by a photo-multiplier tube (PMT, Hamamatsu R6357, Tokyo, Japan), 
after passing through the dichroic mirror (reflect <490nm, transmit >490nm) 
and a 500-550nm band-pass (BP) filter. SHG signal was collected in the for-
ward direction using a condenser (NA=0.55) and filtered by a diaphragm and a 
440-460nm band-pass filter before entering PMT for detection. With the in-
trinsic optical sectioning characteristics for non-linear optical process, the pin-
hole function of the confocal microscope was not used.  
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Figure 4. Schematic illustration of the optical configuration. Excitation laser 
was a tunable mode-locked laser (710 to 990nm set at 900nm) with a pulse 
compressor (PC) and an acousto-optic modulator (AOM) for power control. 
The laser went through a dichroic mirror , an objective lens (20X, NA=0.5), 
and reached tissue specimen. Second harmonic generation (SHG) signal was 
collected at the opposite side the laser source, in the transmitted mode, by a 
condenser (NA=0.55), through a field diaphragm, and a 440-460nm bandpass 
(BP) filter, before being recorded by a photomultiplier tube (PMT). Two-
photon excited fluorescence (TPEF) was collected by the objective lens, fil-
tered by a 500-550nm band-pass filter, before being recorded by another PMT. 
4.2.10 Image acquisition 
Based on the nonlinear optical microscope setup, unstained samples from two 
different preparation methods were imaged to compare the image quality. Af-
ter the comparison, the better preparation method was chosen, and total of 
three tile scan images (4096×4096 pixels, ~2mm×2mm each) were taken from 
each tissue specimen, and two specimens were extracted from each animal 
















4.2.11 Image segmentation 
For all images, image segmentation algorithms based on Otsu method [86], K-
means clustering [125], Fuzzy-C means clustering [92] and Gaussian Mixture 
Model [126] were performed to identify collagen areas in SHG channel imag-
es.  
In Otsu method, the threshold that minimizes the intra-class variance is ex-
haustively searched for. It is defined as !!! ! = !! ! !!! ! +   !!(!)!!!(!), 
in which weights !!  are probabilities of the two classes separated by a 
threshold t and !!! are variances of these classes. 
In K-means clustering, k cluster centers are first randomly picked (In collagen 
segmentation, k is 2 as one is for background, the other is for the collagen sig-
nal). Then each pixel in the image is assigned to the cluster that minimizes the 
distance between the pixel and the cluster center. Re-compute the cluster cen-
ters by averaging all the pixels in the cluster, and repeat the process until con-
vergence is attained. 
In Fuzzy-C means clustering, each point has a degree of belonging to clusters 
rather than belonging completely to just one cluster like in K-means. It is 
based on minimization of the objective function: !! = !!"!!!!!!!!! !! −!! !, 1 ≤ ! < ∞, where m is any number greater than 1, !!"   is the degree of 
membership of !! in the cluster j, !! is the ith of d-dimensional measured 
data, !!   is the d-dimension center of the cluster, and ∗  is any norm ex-
pressing the similarity between any measured data and the center. Fuzzy parti-
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tioning is carried out through an iterative optimization of the objective func-
tion shown, with the update of membership !!" and the cluster centers !! by: 
!!" = !!!!!!!!!!! !!!!!!!!  , !! =
!!"!∗!!!!!! !!"!!!!! . The iteration will stop when 
!!"!" !!"(!!!) − !!"! < !, where ε is a termination criterion between 0 and 
1, whereas k are the iteration steps. The procedure converges to a local mini-
mum of Jm. 
In Gaussian Mixture Model, it is assumed that the histogram of intensity of 
pixels in the image can be modeled as the mixture of two Gaussian distribu-
tions, one representing pixels belonging to collagen area with strong SHG sig-
nals and the other representing the rest of the pixels belonging to non-collagen 
area. Using the Expectation-Maximization (EM) algorithm [126], the parame-
ters of the Gaussian distributions were estimated. For all image segmentation 
algorithms used, a binary image was generated by applying value 1 to all the 
pixels having intensity that belongs to collagen area and value 0 to the rest of 
the pixels. 
For TEPF channel images, pixels in the images were clustered into 3 different 
groups depending on pixel intensity: completely dark, dim, and bright which 
represent areas of the vessel or outside-tissue-space, bile duct proliferation ar-
ea, and hepatocytes respectively. The clustering was performed by a Fuzzy-C 
means clustering method [127], in which each pixel was clustered into one of 
three clusters based on pixel intensity level. A binary image was generated by 
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applying value 1 to all the pixels belonging to the cluster that represents bile 
duct cell areas and value 0 to the rest of the pixels. 
4.2.12 Features extraction and quantification 
Four features were quantified, namely total collagen area percentage, bile duct 
proliferation area percentage, collagen in bile duct area percentage, and rem-
nant hepatocytes area percentage as shown in Figure 5 and elaborated below. 
Collagen area percentage is defined as the numbers of pixels that belong to 
collagen in the region divided by the total area.  
Bile duct proliferation area percentage is defined as the numbers of pixels that 
belong to bile duct cells in the region divided by the total area.  
The collagen in bile duct area percentage is defined as the number of pixels 
that are collagen and also in bile duct cells area divided by the total area of the 
sub-capsular region. The binary image of collagen in the bile duct area is gen-
erated by multiplying the binary images of the collagen area and the bile duct 
cell area.  
Remnant hepatocytes are defined as those hepatocytes that are surrounded by 
bile duct cells. Morphological operations such as erosion, dilation and filling 
holes are performed on the binary image of bile duct cell to identify areas sur-
rounded by bile duct cells. If these areas belong to the cluster that represents 
hepatocytes, they are recognized as the remnant hepatocytes area. The rem-
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nant hepatocytes area percentage is defined as the numbers of pixels that be-
long to the remnant hepatocytes area divided by total area.  
 
Figure 5. Flow chart of the feature extraction algorithms. TPEF and SHG two image 
channels were separated from the same imaging samples. The TPEF channel was 
then clustered into three separate masks by intensity difference, namely bright, dim 
and dark. The bright intensity area in the TPEF channel was classified as hepatocytes 
mask, the dim area was classified as bile duct cell mask and the dark area was classi-
fied as vessel mask including outside-tissue-space. Collagen mask in the SHG chan-
nel was obtained after segmentation performed on the images. The feature of total 
collagen area was then referred to collagen mask, and bile duct proliferation area to 
bile duct cell mask. Multiplying collagen mask and bile duct cell mask yielded the 
collagen in bile duct area feature. The remnant hepatocytes area feature was defined 
as clusters of hepatocytes that were surrounded by bile duct cells, therefore, we ob-
tained it by filing holes of the bile duct cell mask, and then multiplying it by hepato-
cytes mask. 
All image processing and algorithm computations were carried out in 
MATLAB (The Math Works, Inc, Natick). Image processing algorithm code 
















4.3 Results and Discussions 
4.3.1 Zebrafish liver specific gene identification 
Zebrafish (Denrio rerio) has proven to be excellent vertebrate model organism 
for studying human biology and disease. The adult Zebrafish liver, similar to 
human, consists of two lobes and is surrounded by blood vessels. Besides the 
structural similarity, database mining results revealed that the majority of liv-
er-enriched genes in Zebrafish share high homology with their mammalian 
counterparts, suggesting that the profile of liver-enriched genes in an adult 
Zebrafish liver is similar to that identified in mammals and other vertebrates 
[128, 129]. Due to its unique advantage of being fast in reproduction with 
large offspring in each generation, reverse genetics TILLING (Targeting In-
duced Local Lesions in Genomes) [130] is performed on Zebrafish in this 
study to identify a specific liver enriched mutant fish.  Later, a mutant 
Zebrafish line can be constructed, and fibrogenesis model can be established 
by chemically treating the fibrosis-prone fish, also fibrogenesis in different 
stages of the life cycle of Zebrafish can be studied.  
Out of the 129 genuine liver-enriched genes recently identified in Zebrafish 
that is regulated by Hepatocyte nuclear factor (HNF) factors [131], hgf-like 
gene (accession number NM_152980 in GenBank), which is co-regulated by 
HNF3, HNF4, HNF6 is chosen as the target gene for mutant screening in 
Zebrafish mutant library we constructed. This gene is chosen as it is closely 
related to Hepatocyte Growth Factor (HGF), which has a major role in embry-
onic liver development, in adult liver regeneration (reverse of fibrosis) and in 
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wound healing [132]. Deficiency in this gene is therefore expected to make 
Zebrafish more prone to fibrogenesis and hard for liver regeneration, an ideal 
fibrosis model for our study. 
4.3.2 Mutant Zebrafish screening 
For construction the cDNA Zebrafish mutant library, founder animals were 
mutagenized with ENU and 1056 healthy F1 male and female fish were raised 
and used to construct the library (Figure 6). Instead of conventional practice to 
generate a permanent resource by cryopreservation of sperm or testis samples, 
we maintained the library as a living resource that can be used for a limited 
time. The advantage of having a living resource is that, firstly, the cryopreser-
vation of testis or sperm samples is labor intensive, taking several months to 
complete, whereas the construction of a living library only took weeks. Sec-
ondly, the success-rate for the recovery of fish carrying mutations from frozen 
testis samples by in vitro fertilization (IVF) turned out to be highly variable, in 
some cases resulting in loss of alleles. 
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Figure 6. Male Zebrafish were mutagenized with ENU and outcrossed with wild-type 
females to generate a library of 1056 mutagenized F1 fish. Both males and females 
were finclipped and grouped in 88 pools of 12 fish per fish tank. DNA was isolated 
from the finclips and arrayed in eleven 96-well PCR plates. 
PCR amplicons for hgf-like gene are designed from cDNA sequence. This se-
quence is used as input for GENOTRACE [133] to determine the genomic or-
ganization and retrieve noncoding sequences flanking the exons. As a result, 
three exons exsit for hgf-like gene, position of 4853-5621, 15743-17081, 
24312-25603 from the genome DNA (Figure 7). Noncoding introns were used 
for primer design to amplify the coding exons. First and nested primers were 
designed accordingly for these cDNA fragments, however one amplicon is 
unable to amplify the cDNA. Failure of one amplicon is mostly likely due to 





Figure 7. Amplicons design of hgf-like gene on genome DNA (gDNA) of Zebrafish. 
Three cDNA fragments were identified in gDNA, six pairs of primers (one pair of 
first round primers and one pair of nested primers for each exon) for exons were de-
signed accordingly. Two exons can be amplified, while one exon cannot be amplied 
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The four pairs of successfully designed primers are used for cDNA amplica-
tion and sequencing of the two exon fragments. Sequencing results are col-
lected in e-form, with request to mark the base “N” when the lower peak is 
over 30% of the higher peak on the same base point position, which is a suspi-
cious candidate of the mutation. After aligning all sequencing results together 
with standard gDNA in the database, dissimilarities are identified manually in 
the exons region. As demonstrated in Figure 8, suspicious point mutations are 
identified by the sequencing results. However, after redoing the first and nest-
ed PCR by tracing back the original gDNA samples and sequenceing the PCR 
products, it confirmed that all the suspicious mutations screened earlier on 
were not real mutation. 
 
Figure 8. cDNA sequencing results from hgf-like gene of mutant Zebrafish against 
normal genome DNA. Suspicious point mutant is marked with N in the sequencing 
results, as shown by red arrow. 
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It is expected that ENU mutagenesis is random for coding and noncoding se-
quences. With coding region is much smaller than the noncoding region, the 
chance that the coding exons are mutanted is quite small. In general, the suc-
cess rate of both forward and reverse mutagenesis screens is mainly dependent 
on two factors, mutagenesis efficiency and the number of individuals 
screened. To find loss-of-function mutations in target genes, both factors 
should be as high as possible. In our experiment design, only 1056 Zebrafish 
were used to construct the library, which is insufficient compared with other 
groups [134, 135]. That would account for the unsuccessful screening of the 
desired gene in the experiment. 
After the unsuccessful screening of hgf-like mutant Zebrafish, we stopped the 
direction of building a liver fibrosis model on fish. Since our Zebrafish library 
is not big enough for mutant screening and drug induced fibrosis in fish is not 
very obvious (proved by previous labmates, data not shown), the feasibility of 
building a fibrotic model on Zebrafish is low in the short period. Therefore, 
we move on to build the fibrotic model on rats, a common mammal model. 
4.3.3 Rat BDL model fibrosis staging 
Hepatic fibrosis induced by Bile Duct Ligation (BDL) is the primary patholog-
ical lesions occur surrounding the bile duct epithelium. The maneuver of BDL 
introduces biomechanical stress to biliary epithelium and initially triggers the 
compensatory proliferation and expansion of biliary epithelial cells (BECs) 
[136, 137]. Following this epithelial mitogenic phase, chronic obstruction of 
bile duct causes massive activation of myofibroblasts in the periductal region 
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and ultimately results in biliary fibrosis/cirrhosis. It is an established animal 
model that simulates the progression of Primary Biliary Cirrhosis (PBC) 
[138], which is characterized by destruction of interlobular and septal bile 
ducts leading to chronic cholestasis, cirrhosis and hepatic failure [139]. The 
disease progression is also similar to Biliary Atresia (BA), the most serious 
digestive disease affecting infants, caused by obstruction of bile flow [140, 
141]. Considering the surgical difficulties in operation on small animals, we 
established the BDL surgical model on rats to induce liver fibrosis. As shown 
in Figure 9, liver of BDL rat is distinguishable from normal liver, as BDL liv-
ers are larger in size after surgery and appear to have less blood flow within 
the organ. The surface of the BDL liver is rough compared with the smooth 
liver surface from the normal rat, a clear indicator of presence of liver fibrosis. 
The bile duct is easily identifiable in the BDL rat, indicating the success of 
inducing fibrosis through bile duct ligation. 
 
Figure 9. Normal rat liver and rat liver after Bile Duct Ligation (BDL). 4 weeks after 
bile duct ligation, rat liver (b) is larger than normal liver (a), caused by hyper pressure 
from bile flow within the liver and the proliferation of biliary epithelial cells (BECs). 
Less blood flow is also present is the BDL liver evident by lighter liver color (b) 
compared with normal liver (a). Due to pressure caused by ligation, bile duct thick-
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ens, making it easily identifiable after BDL (b). Liver surface also roughens after 
BDL. 
After extracting the liver samples, tissue blocks from both left and right lobes 
were prepared. Two successive slices cut from the same tissue block were 
separately stained with Masson’s Trichrom and Sirius red. Comparing differ-
ent staining results from the same sample can therefore help with identifica-
tion of morphological changes based on feature extraction and reduce varia-
tions of fibrosis staging. Figure 10 shows the same sample with two different 
stainings. With both Sirius red and Masson’s Trichrome, we can clearly identi-
fy hepatocytes and collagen near the blood vessels and ECM (arrows in Figure 
10 a and b). 
 
Figure 10. Sirius red staining (a) and Masson’s Trichrome staining (b) of the same 
fibrotic BDL liver tissue. In Sirius red staining (a), hepatocytes were stained dark red, 
and collagen of light red in pale yellow background. In corresponding Masson’s Tri-
chrome staining, hepatocytes were stained dark red with nuclei black, and collagen of 
blue. Collagen near blood vessel and in ECM can both be observed in the two stain-
ing indicated by yellow arrows. 
After staining all the liver samples, samples were sent to pathologists for read-
ing and staging based on modified Ruwart scoring [124, 142]. Figure 11 
shows changes in collagen using Masson’s Trichrome staining of different 
stages in our samples. In normal livers, hepatocytes were healthy and presence 
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of collagen was minimal, mainly around blood vessels [Figure 11(a)]. As liver 
progressed in the animal models, stage 1 fibrosis with an increase in pericellu-
lar collagen without formation of septa was evidenced [Figure 11(b)]. With 
the continuous progression of liver fibrosis after BDL, disuse loss of hepato-
cytes and significant bile duct proliferation was observed. Stage 2 collagen 
aggregations also formed incomplete septa from the portal tract to the central 
vein [Figure 11(c)]. Stage 3 moderate liver fibrosis was characterized by bile 
duct proliferation, biliary ductular hyperplasia, diffuse loss of hepatocytes and 
occasional small foci of mature collagen. In Figure 11(d), complete but thin 
collagen septa interconnected with each other to divide the parenchyma into 
separate fragments in stage 3 fibrosis. Stage 4 severe fibrosis was mostly evi-
denced by massive hepatocytes loss, substantial biliary ductular hyperplasia 
and severe diffuse fibrosis. Thick collagen septa were observed, forming com-
plete cirrhotic nodules in Figure 11(e). Here unique to BDL model was the 
amount of bile duct proliferation and collagen aggregation around the bile 
ducts, the dimmer red regions in Masson’s Trichrome staining. Although Mas-
son’ Trichrome staining is regarded as the gold standard in a typical pathology 
laboratory for clinical diagnosis of liver fibrosis [143], the color of the staining 
is not uniform across all the samples as shown in the figure, therefore making 
it lack of objectivity for quantifications. 
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Figure 11. Morphological changes at different stages (b-e) of liver fibrosis compared 
with normal liver (a) recorded with conventional Masson’s Trichrome staining. Nor-
mal liver (a) has minimal presence of collagen in the tissue, and mainly around blood 
vessels. In stage 1 liver fibrosis, there was presence of pericellular collagen without 
the septa formation in (b). In livers with stage 2 fibrosis (c), collagen aggregations 
formed incomplete septa from the portal tract to central vein, the bile duct prolifera-
tion was seen as dim red regions in the image. For stage 3 liver fibrosis (d), profuse 
bile duct proliferation was observed all over the tissue sample, where complete but 
thin collagen septa interconnected with each other. In stage 4 fibrosis (e), thick colla-
gen septa were observed, forming complete cirrhosis. All scale bars are 500 µm. 
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4.3.4 Image acquisition from prepared samples 
Two sample preparation methods for SHG/TPEF imaging were tried out to 
compare the image qualities. As shown in Figure 12, images scanned based on 
SHG/TPEF imaging were presented, with red color in both images represent-
ing the cells in the liver tissue, mainly hepatocytes, green color representing 
collagen type I. Different red color represents different cell types in the liver, 
as the auto-fluorescence from different cells types have different excitation 
wavelength. Areas containing nucleus, lipid droplets and vacuoles formed by 
degenerated hepatocytes appear dark as they are lacking of fluorescent mole-
cules in such areas. Comparing Cryosection prepared samples with paraffin 
embedded section prepared samples [Figure 12(b)], we can see that although 
even finer collagen (green) can be both picked up in these two images, cell 
morphology is much clearer in the image with paraffin embedded section 
[Figure 12(b)], while in Cryosection samples [Figure 12(a)], cells are lacking 
of clear boundary, also there appear to be more small black holes in the sam-
ple. We suspect, during Cryosection, the freezing step made water in the cells 
expand in volume, therefore when defreezing, pressure from within the cells 
expanded the cells, and finally broke them. That caused the changing of mor-
phology and the big holes in the samples. After the comparison, we have de-




Figure 12. Comparison of SHG/TPEF images from Cryosection (a) and paraffin em-
bedded section (b) preparation. In both 20x images, SHG is shown in green, repre-
senting type I collagen and TPEF is shown in red, representing liver cells. In Cryo-
section prepared sample (a), the cell morphology is less clear than the paraffin em-
bedded section (b), also there are small black holes in the tissue sample which are not 
visible in paraffin embedded one. In both images, SHG signals are very strong, being 
able to pick up fine collagen fibers in the tissue samples. Scale bar is 500µm. 
After confirming to use only paraffin embedded section samples for 
SHG/TPEF imaging, three tile scan images (4096×4096 pixels, ~2mm×2mm 
each) were taken from each tissue specimen, and two specimens were extract-
ed from each animal (from both left and right lobe of the liver). In the tile scan 
image [Figure 13(a)] from fibrotic liver tissue, larger area of the tissue block 
as covered, and more structures such as portal tracts and central veins were 
revealed. The detailed image [Figure 13(b)] showed that the morphology of 
the liver tissue is clearly visible, with hepatocytes shown in light red color and 
black dots in the cells representing nuclei. Separating the overlay image into 
TPEF [Figure 13(c)] and SHG [Figure 13(d)] channels, we can identify that 
thick collagens (in green color) in the center of the figure are around the blood 
vessels, matching the standard morphology structure of the liver tissue. Also, 
thin collagens along hepatocytes were clearly visible, making this image mo-
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dality sensitive to abnormal collagen during fibrogenesis. The dark red regions 
in the images where clear hepatocytes morphology was not indentified were 
suspected to be filled with Biliary epithelial cells (BECs), as our BDL model 
is likely to cause profuse proliferation of bile ducts. This will be proved fur-
ther when comparing with gold standard stained liver tissues. 
 
Figure 13. Images of liver tissue from SHG/TPEF image modality. Tile scan image 
(a) (4096×4096 pixels, ~2mm×2mm) was taken from paraffin embedded section tis-
sue slice. Detailed overlay image (b) showed that liver morphology is clearly identifi-
able, and signals from both TPEF channel (c) and SHG channel (d) overlay perfectly 
to reveal the liver structure. Thick collagen around blood vessel and thin collagen 
along hepatocytes match the standard structure of a BDL fibrotic liver. TPEF signal is 
in red, and SHG signal is in green, scale bar is 100µm. 
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4.3.5 Comparison between SHG/TPEF and conventional histological images 
To compare SHG/TPEF imaging modality with the conventional stained tissue 
imaged under wide filed, images from the same location taken from two dif-
ferent image modalities were compared as shown in Figure 14. Both images 
revealed the same morphology in the tissue, with collagen shown in blue and 
hepatocytes in red in Masson’s Trichrome image and collagen shown in green 
and hepatocytes in red in SHG/TPEF image. The pink color stain in Masson’s 
Trichrome image represented biliary epithelial cells, correspondingly, in 
SHG/TPEF image, they were shown in dark red color. Both images also clear-
ly demonstrated collagen aggregation around vessel walls and inside the si-
nusoids. In Figure 14, however, there seem to be more blue color in Figure 
14(a) than green color in Figure 14(b). That is because SHG signal can only 
show type I collagen fibers, while in the stained tissue, all types of collagens 
were stained in blue. However, to use stained samples for quantification, there 
lies a particular challenge, as it is difficult to produce uniform interbatch 
shares of the three colors involved in Masson’s Trichrome staining. In addi-
tion, in Masson’s Trichrome staining, both green and blue colors can be used 
to stain collagen in the tissue, causing nonreproducible results when used as a 
quantitative measures of fibrosis progression. Therefore, using SHG/TPEF 
image modality can truthfully reveal the morphology of the liver tissue struc-
ture and the collagen distribution, making it a sound methods for quantitative 
measures of fibrosis progression. 
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Figure 14. Comparison between Masson’s Trichrome stained tissue image and 
SHG/TPEF image. White field transmission image of a fibrotic tissue sample stained 
with Masson’s Trichrome (a) and SHG/TPEF image (b) of the same sample before 
staining were compared. The overlay of the image confirmed that SHG/TPEF image 
can present the liver tissue morphology and collagen distribution faithfully. The light 
red color in both (a) and (b) images represents hepatocytes, and pink in (a) and dark 
red in (b) represent biliary epithelial cells, and green in (b) represents collagen corre-
sponding to blue in (a). Both collagens around the vessel wall and in sinusoids can be 
detected in (b), making SHG/TPEF a comparable imaging modality to reveal tissue 
structure. 
4.3.6 Comparison among different image segmentation methods 
To truthfully extract information from SHG/TPEF images, especially the vital 
features, such as the presence of collagen in the liver organ, different image 
segmentation methods were employed. 
In our search for the optimal method to segment fibril collagen from the back-
ground, four different methods were employed, namely Otsu thresholding, K-
means clustering, Fuzzy-C means clustering (FCM) and expectation maximi-
zation (EM) algorithm based on Gaussian mixture model (GMM). They each 
represent a typical image segmentation method group. Otsu method is a clas-
sic global thresholding algorithm, which aims to find the best threshold to 
minimize intra-class variance and maximize the between-class variance. The 
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K-means clustering is one of the most popular and iterative clustering methods 
for image classification. The Fuzzy-C means clustering method works similar 
to K-means clustering while assigning each pixel in the image a degree of be-
longingness (membership) to clusters rather than strictly assigning to one clus-
ter. It handles the uncertainty in the data. The Gaussian Mixture Model 
(GMM) method assumes that the distribution of intensities is a mixture of sev-
eral Gaussian distributions, each corresponding to a separate tissue class. Us-
ing Expectation Maximization (EM) algorithm, it is assumed that the intensity 
of pixels in the SHG image can be modeled as the mixture of two Gaussian 
distributions, one representing collagen area with strong SHG signals and the 
other representing the background. 
The segmentation results using different segmentation methods are shown in 
Figure 15. Figure 15(a) is the original SHG image as captured by microscope, 
Figure 15(b-e) represents the segmentation results from Otsu, K-means, 
Fuzzy-C means and GMM respectively. As shown in the results, Otsu, K-
means and Fuzzy-C means can segment most of the thick collagen from the 
images, however, the dim and finer collagen fibers cannot be picked up by the 
three methods. Using Gaussian Mixture Model (GMM), on the other hand, can 
achieve better segmentation results compared to the other methods by captur-
ing finer collagen while incurring minimal noise in the image. Based on the 
results we have obtained, we concluded that GMM is a better segmentation 
method for the purpose of extracting collagen fibers in the SHG images. 




Figure 15. Segmentation results of SHG image using different methods. (a) Original 
SHG image, (b) segmentation results using Otsu method, (c) K-means clustering 
method, (d) Fuzzy-C means clustering method and (e) Gaussian mixture modeling. 
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4.3.7 Image analysis and feature extraction of SHG/TPEF images 
To stage liver fibrosis, different features within livers were extracted and 
quantified accordingly. In the TPEF channel, liver cells were separated into 
hepatocytes, which were marked as light red color in the image (Figure 16(b)), 
biliary epithelial cells, the dark red color in the same image. The segmentation 
of TPEF channel was done by using Fuzzy-C means, which classifies the 
TPEF image intensity into three different groups, the bright, the dim and the 
dark. An image mask was created on both the bright and the dim intensity cat-
egory, which represents the hepatocytes (not shown) and bile duct area (Figure 
16(d)) respectively. The goodness of this segmentation method was verified 
by pathologist-assisted color segmentation performed on Masson’s Trichrom 
stained tissues, the detail of which is shown in the next point. After segmenta-
tion of both SHG and TPEF channel images, the biliary epithelial cell content 
(Figure 16(d)) was then quantified as percentage of the total area in the imag-
es, marked as bile duct area. Total collagen in the images was quantified as the 
percentage of the collagen in the area (Figure 16(c)), also as collagen percent-
age in the bile duct area (Figure 16(e)). Some hepatocytes in the tissue were 
further quantified as percentage of remnant hepatocytes (Figure 16(f)) defined 
as small clusters of hepatocytes that were surrounded by the bile duct cells. In 
all, 4 types of features were extracted from each image taken from liver tissue: 
total collagen content in the tissue; bile duct area; collagen content in the bile 
duct area, representing the abnormal and destructive ECM distribution in the 
BDL disease model; and finally, the remnant hepatocytes, representing the 




Figure 16. Process of feature extraction from SHG/TPEF images. Images from SHG 
(a) and TPEF (b) channels were separated from the same combined image. After 
segmentation of both channel images, collagen content in the whole area (c) and bile 
duct areas (d) corresponding to the dark red region in (a) was quantified. Collagen 
content in the bile duct area (e) was also quantified as the abnormal, destructive ECM 





were surrounded by the bile duct cells, were also quantified as potential necrotic and 
apoptotic hepatocytes. 
4.3.8 Validation of feature extraction of SHG/TPEF images 
To validate the goodness of the image segmentation performed, the segmenta-
tion results are compared to the semi-automatic segmentation performed on 
the Masson’ Trichrome stained tissues, in which color segmentation were per-
formed, and verified and hand corrected by pathologist. 
Masson’ Trichrome stains collagen blue, cytoplasm red and cell nuclei dark 
brown. Based on this color information, we segmented the MT stained tissue 
into two channels as shown in Figure 17, one containing blue collagen (Figure 
17(b)), and the other containing red cellular information (Figure 17(c)). In the 
cellular channel, we further segment the cell types based on the color differ-
ence, with hepatocytes stained in dark red and bile duct cells in light red. De-
pends on the precision of staining process, the color difference between differ-
ent cell types might not be clear enough for the automatic color segmentation. 
Hence, after segmentation of the image based on pixel color information, we 
consulted the pathologist, and did a second round of manual segmentation to 
ensure the accuracy of the results. Since manual reading of the histopathologi-
cal staining tissue is still the gold standard in current clinical practice [3], this 
manual segmentation is a critical step for conventional fibrosis assessment. 
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Figure 17. Masson’s Trichrome image segmentation. Masson’s Trichrome image (a) 
taken from a white light microscope is segmented based on color information into 
two channels. Blue color in the image representing collagen is segmented into chan-
nel (b), while red color representing all the cell types is segmented into channel (c). 
To validate the accuracy of the segmentation methods we employed in this 
thesis study, segmentation of both MT image and SHG/TPEF image was 
compared for the same tissue sample for respective features shown in Figure 
18. Figure 18(c, e, g) shows the pathologist-assisted segmentation of collagen, 
hepatocytes and bile duct cells respectively done on the MT image (Figure 
18(a)), while the corresponding SHG/TPEF image segmentation is shown in 
Figure 18(d, f, h). Judging from the images shown, our automated image seg-
mentation simulate very closely on the pathologist-assisted method. And to 
prove this in a quantitative manner, same 100 random regions with size 1/100 
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of the image displayed in the corresponding segmented images were chosen. 
Percentage of the segmented features were calculated, and compared between 
two different segmentation methods. The results are shown in Figure 19. Scat-
ter plot indicates that among three features we segmented, they all have close 
correlation with the pathologist-assisted results. Correlation coefficient R cal-
culated in the Figure 19 also suggests that this correlation is statistically sig-
nificant (p<0.01), and that we can proceed with the feature quantification 





Figure 18. Masson’s Trichrome and SHG/TPEF image features segmentation com-
parison. Masson’s Trichrome image (a) and SHG/TPEF image (b) from the same tis-
sue sample are obtained and segmented based on pathology-assisted color segmenta-
tion and automated segmentation respectively. (c), (e), (g) represent collagen, hepato-
cytes and bile duct segmentation from MT image (a), while (d), (f), (h) represent the 
same features from SHG/TPEF image (b). 
 
Figure 19. Segmentation results comparison. Based on the feature percentage calcu-
lated from the 100 random regions in the image, scatter plots of the same feature be-
tween two different segmentation methods are shown. (a), (b), (c) show the plot of 
collagen, hepatocytes and bile duct segmentation respectively. Correlation coefficient 
of the linear relationship between these two segmentation methods are indicated in 
the plots, suggesting statistical significance of the segmentation results similarity. 
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4.3.9 Quantification analysis of liver fibrosis 
Based on the features extracted on SHG/TPEF images, each feature was quan-
tified as the area percentage of such feature presented the images. X-axis rep-
resents time after bile duct ligation, which is the time course of fibrosis pro-
gression, with week 0 representing the normal liver tissues. As shown in the 
quantification results below, with the increase of liver fibrosis progression, 
there is an increasing amount of collagen in the liver tissue. With the tremen-
dous increase of bile duct area in the liver tissue, collagen distribution in the 
bile duct region (abnormal collagen) also increased. All these three features 
show significant difference among different time points after Bile Duct Liga-
tion (p<0.01). Potentially remnant hepatocytes also increased in percentage in 
the liver tissue. However, although significant difference (p<0.01) showed in 
early development of fibrosis progression (among week 0, 2, 4), increase be-
tween week 4 to week 6 is not statistical significant. It could mean that at the 
late stage of fibrosis progression, since mass necrosis and apoptosis occur in 
the liver, the potentially remnant hepatocytes are not increasing as much as in 
the early stages. Also the difference between total collagen in the tissue and 
the collagen distributed in the bile duct areas (abnormal collagen) remains sta-
ble across all time points, suggesting that the fibrosis progression has not 
much influence on the distribution of normal collagen in the tissue. 
In all, based on the four features extracted, we can quantitatively monitor the 
fibrosis progression in time. Each feature can be used separately as the clear 
indicator of the disease progression. 
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Figure 20. Quantitative analysis results of features extracted in SHG/TPEF images. 
Four features, collagen: collagen content in the tissue, collagen in bile: collagen con-
tent in the bile duct region, bile: bile duct region percentage in the tissue, remnant 
hepatocytes: potentially remnant hepatocytes content in the liver tissue were quanti-
fied as percentage of such features in the liver tissue in the images. At different time 
points after bile duct ligation, all features showed a trend of area percentage increase 
in the images with significant significance (p<0.01) among all time points except for 
remnant hepatocytes between week 4 and week 6. 
In order to see if such quantitative assessment agrees with the traditional 
qualitative histopathology staging, we prepared samples in Masson’s Tri-
chrome staining and asked a pathologist to give each of those tissue samples a 
numerical score based on the severity of fibrosis (Metavir scoring system, 0 
represents no fibrosis, 4 represents Cirrhosis), known as the ‘gold standard’ 
for liver fibrosis staging. Since both left and right lobes were extracted from 
the same rat, and each lobe is prepared into one tissue sample for the 
pathologist’s staging, and four rats in each time group, the final histopathology 
score of each time point is an average score of all the tissues staged. As shown 
in Figure 21, using the same x-axis as in Figure 20, with the progression of 
 70 
liver fibrosis in time, the severity of the disease progresses, with the same in-
creasing trend of all the quantitative features we extracted early on. Therefore, 
we confirmed that the quantitative assessment of liver fibrosis based on the 
information from SHG/TPEF images could represent the real disease progres-
sion in sample, with a quantitative nature. 
 
Figure 21. Histopathology scoring results of liver tissues. At different time points 
after performing bile duct ligation, liver tissues were scoring based on Metavir scor-
ing system, with numerical results of 0, 1, 2, 3, 4 only. Values shown are averaged 
over all tissue samples at the given time point, showing liver fibrosis severity increase 




We have established a reliable rat bile duct ligation (BDL) model for liver fi-
brosis study, in which liver fibrosis progress with time after the induction of 
the disease. With the digitized images we took from SHG/TPEF microscopes, 
four morphological features were extracted from liver tissues, allowing for 
quantitative assessment of the features. We therefore developed and validated 
a standardized quantification system in liver fibrosis assessment based on the 
features extracted. We further demonstrated the feasibility of our SHG/TPEF 
microscopes in monitoring liver fibrosis progression with the BDL animal 
model by comparing with the conventional ‘gold standard’ histopathological 
scoring system. With the fast tissue preparation process compared with the 
traditional staining preparation, and the quantitative and standardization nature 
of the SHG/TPEF imaging modalities, our assessment system allows for future 
application of SHG/TPEF microscopies in diagnosis and prognostication of 
disease complications. By incorporating the morphological features with 
strong biological meanings in the tissue samples for quantification, we can 
also minimize the intra- and interobserver discrepancies by providing stand-
ardized features that are widely accepted by pathologist for staging. 
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Chapter 5 Towards Surface Quantification of Liver Fibrosis Pro-
gression 
5.1 Introduction 
Liver fibrosis is a wound healing process in response to various toxic injuries, 
and associated with almost all chronic liver diseases [1, 2, 24]. Inflammatory 
responses and excessive deposition of extracellular Matrix (ECM) are often 
observed with cirrhosis marking the end stage of fibrosis that represents the 
major causes of morbidity and mortality worldwide. There is increasing evi-
dence that fibrosis is treatable and reversible in its early stages [144-147]; and 
even cirrhosis can regress in some clinical studies [148]. Therefore, accurate 
staging of liver fibrosis is of paramount importance to determine the state of 
disease progression, responses to therapy and optimization of treatment to di-
rect disease management [44]. 
Currently, researchers have reported many noninvasive methods to assess liver 
fibrosis. Putative serum markers of fibrosis have been evaluated for the as-
sessment, with indirect markers including serum aminotransferase levels [149, 
150], presence of coagulopathy and platelet counts [151-153] that reflect alter-
ations in hepatic functions; and markers including laminin [154], cytokines 
[155], collagens [156], matrix metalloproteinase and tissue inhibitors of metal-
loproteinases [157, 158] that reflect serum ECM deposition and turnover. Alt-
hough some serum assays have been developed to diagnose significant fibrosis 
and cirrhosis with accuracies [159-161], none of them has been validated as a 
surrogate marker to stage fibrosis due to low sensitivity or non-specificity 
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[56]. Radiological imaging and novel imaging modalities such as ultrasonog-
raphy [162], transient elastography [163] and magnetic resonance elas-
tography (MRE) [60, 164] that based on liver stiffness measurements (LSM) 
have been shown to be reliable tools to assess liver fibrosis with quick and 
good reproducibility, but the sensitivity is also less satisfactory with current 
studies. 
Percutaneous liver biopsy still represents the gold standard for the diagnosis 
and assessment of liver fibrosis. However, the potential complications follow-
ing liver biopsy, and inherent drawbacks such as the invasive nature of the 
procedure, sampling error and inter- and intraobserver variability in the inter-
pretation of the needle biopsy results have discouraged routine practice [4, 5, 
48-50]. In addition, it is impractical to perform serial liver biopsies to accu-
rately determine the changes of disease progression or to monitor the treat-
ment effects. 
To specifically and accurately monitor liver fibrosis in a quantitative manner, 
information extracted has to be directly compared to morphological features 
recognized by histological examination of liver biopsies’ samples. Imaging on 
the liver surface, especially over a large sampling area than from biopsy, 
would therefore give us the potential to extract enough information over a 
long period of time, without the complication brought forth by the invasive 
biopsy. Laparoscopy has been attempted to diagnose cirrhosis by surface 
scanning to detect presence of nodules and the hardening of the tissue [165, 
166]. However, with a thick layer of capsule around liver organ, traditional 
imaging technology can only focus on the capsule layer without penetration 
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into the tissue, making it hard for laparoscopy to extract quantitative infor-
mation based on histological information that is comparable with biopsy sam-
ples. 
In recent years, SHG microscopy has been increasingly used to measure struc-
tural protein such as neuron, muscle and collagen in biological samples with 
special structural properties [79-81, 167]. As a non-linear optical process, 
SHG exhibits intrinsic advantages over conventional fluorescence by requiring 
no fluorophore presence in tissue; therefore signals are not affected by dye 
concentration and photobleaching. Deeper tissue penetration can also be 
achieved by using infrared-range excitation source, resulting in less scattering 
in tissues than that in visible wavelength range [112-114, 116, 168]. SHG has 
been applied for assessing fibrosis by quantitative measurement of collagen in 
various organs [13, 81, 115], including livers [82, 118, 119, 169]. The results 
obtained using SHG/TPEF are standardized, highly reproducible and can mon-
itor the progression and distribution of collagen at all stages of liver fibrosis 
with agreement with pathological readings [118, 169].  
To incorporate such properties of SHG and TPEF imaging modalities for po-
tential liver surface scanning to overcome the current drawbacks from lapa-
roscopy, it is important to assess whether the SHG/TPEF based methods can 
extract surface information that reflects the whole organ, especially the interi-
or that biopsy samples are usually obtained. The surface distribution of liver 
fibrosis features also needs to be examined to direct future scanning area on 
the liver surface. Therefore, fully automated quantification algorithms were 
developed in this chapter to extract morphology-based features from both liver 
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surface and the interior of the organ. Analysis of these features was performed 
to compare with the gold standard (histopathological scorings) to validate fea-
tures, and then to study the representativeness of surface area to the liver inte-
rior. We observed that liver anterior surface on both left and right lobe contain 
similar information as in the liver interior when imaged and extracted using 
SHG/TPEF imaging modalities for fibrosis analysis. This establishes the 
foundation for future development of laparoscopic non-linear optical methods 
to serially quantify liver fibrosis on liver surfaces to eventually eliminate the 
need for invasive liver biopsy. 
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5.2 Materials and Methods 
5.2.1 Rat BDL model sample extraction for surface study 
Bile duct ligation (BDL) of rats was performed as described in Chapter 4. 
Cardiac perfusion with 4% paraformaldehyde was performed to flush out 
blood cells and fix the liver tissue before harvesting. To explore the surface 
information in the liver, sample extraction from liver tissue was performed so 
that the surface of the liver is preserved and exposed for imaging. Liver spec-
imens from both the left lateral lobes and right anterior lobes were preserved 
in paraffin and sectioned with a thickness of 50 µm. 
For reflective 3D surface area study, intact liver lobes were preserved in For-
maldehyde for further imaging use. The Liver surface is the out layer of the 
liver lobe, which is exposed for imaging. 
5.2.2 Histopathological scoring 
Tissue samples were stained with Masson Trichrome (MT) stain kit (Chro-
maView advanced testing, #87019, Richard-Allan Scientific) and whole tissue 
slices were imaged (Aperio Digital Pathology Environment). Animal tissue 
scoring based on whole slice MT images was performed by a pathologist 
based on blind reading to reduce any bias using modified Ruwart score ac-
cording to Boigk et al. since there was extensive bile duct proliferation noted 
[124, 142]. A modified Ishak score [46] was considered and served as a guide 
to align the animal pathological score with clinical human scoring system. 
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5.2.3 Modification of non-linear microscopy 
Similar to Chapter 4, the non-linear optical microscope was developed based 
on a confocal imaging system (LSM 510, Carl Zeiss) using an external tunable 
mode-locked Ti:Sapphire laser (Mai-Tai broadband, Spectra-Physics). System 
is shown in Figure 22. Reflective SHG is built on the other side of the trans-
mission SHG. Reflective SHG signals were collected along the same optical 
path as TPEF, but with a different band-pass filter of 390-465nm, before en-





Figure 22. Schematic illustration of the optical configuration. Excitation laser was a 
tunable mode-locked laser (710 to 990nm set at 900nm) with a pulse compressor 
(PC) and an acousto-optic modulator (AOM) for power control. The laser went 
through a dichroic mirror , an objective lens (20X, NA=0.5), and reached tissue spec-
imen. Second harmonic generation (SHG) signal was collected at the opposite side 
the laser source, in the transmitted mode, by a condenser (NA=0.55), through a field 
diaphragm, and a 440-460nm bandpass (BP) filter, before being recorded by a pho-
tomultiplier tube (PMT). Two-photon excited fluorescence (TPEF) was collected by 
the objective lens, filtered by a 500-550nm band-pass filter, before being recorded by 
another PMT. Reflective SHG signal was collected on the same side as TPEF, 
through the 390-465nm BP filter, and recorded by PMT. 
5.2.4 Image acquisition and segmentation 
A total of twelve SHG/TPEF images (3072 3072 pixels, ~1.38×1.38 mm) 
were scanned in transmission mode for each tissue specimen, with four images 





















gion and four images covering the posterior surface area. Two specimens were 
extracted from each animal, with one from the left lobe and one from the right 
lobe of liver. Reflective images were obtained by scanning from the front size 
of the intact liver lobe. For all images, an image segmentation algorithm based 
on a mixture Gaussian model was performed to remove background and noise 
for SHG channel images. It is assumed that the intensity of pixels in the image 
can be modeled as a mixture of two Gaussian distributions, one representing 
the collagen area with strong SHG signals and the other representing the 
background. Using the Expectation-Maximization (EM) algorithm [126], the 
parameters of the Gaussian distributions which model the peak intensity of 
pixels in the image were found. A binary image was generated by applying 
value 1 to all the pixels having intensity that belongs to the Gaussian distribu-
tion representing collagen area and value 0 to the rest of the pixels. 
5.2.5 Features extraction and quantification 
On the liver surface, the tissue edge was detected from TPEF channel image 
using the Canny method [170], which finds edges by looking for local maxima 
of the gradient of the image. The percentage of collagen of each line, which is 
parallel to the edge, is calculated. The width of the capsule, which is the 
unique feature on surface, is defined as the depth where the percentage of col-
lagen changes most between neighboring lines.  
Four common features on both the surface (sub-capsular region) and in the 
interior of the liver tissues were quantified, namely total collagen area per-
centage, bile duct proliferation area percentage, collagen in bile duct area per-
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centage, and remnant hepatocytes area percentage. Collagen area percentage is 
defined as the numbers of pixels that belong to collagen in the sub-capsular 
region divided by the total area of the sub-capsular region. The segmentation 
of collagen in the SHG channel image is the same as that used for capsule 
identification. Bile duct proliferation area percentage is defined as the num-
bers of pixels that belong to bile duct cells in the sub-capsular region divided 
by the total area of the sub-capsular region. Pixels of the TPEF image were 
clustered into 3 different groups depending on pixel intensity: completely 
dark, dim, and bright which represent areas of the vessel or outside-tissue-
space, bile duct proliferation area, and hepatocytes respectively. The cluster-
ing was performed by a Fuzzy-C means clustering method [127]. A binary im-
age was generated by applying value 1 to all the pixels belonging to the cluster 
that represents bile duct cell areas and value 0 to the rest of the pixels. The 
collagen in bile duct area percentage is defined as the number of pixels that 
are collagen and also in bile duct cells area divided by the total area of the 
sub-capsular region. The binary image of collagen in the bile duct area is gen-
erated by multiplying the binary images of the collagen area and the bile duct 
cell area. Remnant hepatocytes are defined as those hepatocytes that are sur-
rounded by bile duct cells. Morphological operations such as erosion, dilation 
and filling holes are performed on the binary image of bile duct cell to identify 
areas surrounded by bile duct cells. If these areas belong to the cluster that 
represents hepatocytes, they are recognized as the remnant hepatocytes area. 
The remnant hepatocytes area percentage is defined as the numbers of pixels 
that belong to the remnant hepatocytes area divided by total area of sub-
capsular region.  
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All image processing and algorithm computations were carried out in 
MATLAB (The Math Works, Inc, Natick). Image processing algorithm code 
is available for readers upon request.
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5.3 Results and Discussions 
5.3.1 Surface features comparison of SHG/TPEF images and histological im-
ages 
To explore the surface information in the liver, perfused liver organ was har-
vested and tissue samples were extracted to expose the liver surface shown in 
Figure 23(a). Liver samples were then sectioned in the direction perpendicular 
to the surfaces so as to keep the capsular collagen for imaging purposes as 
shown in the inset. To validate the use of SHG and TPEF microscopies to 
quantify morphological changes during fibrosis progression, feature compati-
bility in both the typical pathological sectors and in SHG/TPEF images was 
investigated. A pathological tissue section from a fibrotic liver stained with 
Masson’s Trichrome (Figure 23(b)) is compared to a stain-free SHG/TPEF 
image (Figure 23(c)) from the same location with the pseudo-colors of green 
representing SHG signals and red representing TPEF signals. When compared 
with the stained image and with the help from having the major constituents 
marked out, we can see that both the fibril collagen presented in the internal 
organ and the capsule collagen in the liver surface can be correctly detected by 
SHG signals. Due to the presence of intrinsic molecules such as NAD(P)H and 
flavins that emit substantial fluorescence after excited with femto-pulsed la-
sers[171], hepatocytes were easily seen as bright red cells in the SHG/TPEF 
image (Figure 23(c)). Bile duct epithelial cells were shown in Figure 23(c) as 
the dim red cells due to their lack of fluorescent molecules. The co-
localization of these major features proved that the pathological development 
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of fibrosis on both the surface and in the interior of liver could be well record-
ed by SHG/TPEF imaging for further quantification. 
 
Figure 23. Comparison between histopathological staining and SHG/TPEF images. A 
perfused fibrotic tissue was extracted (a) and sectioned perpendicular to its surface to 
expose the liver boundary (inset in (a)). Masson’s Trichrome staining for a fibrotic 
tissue sample by the directed cutting was shown in (b), with collagen stained in blue 
and cytoplasm in red and cell nuclei in dark brown. The SHG/TPEF image of the 
same sample was shown in (c) with collagen in pseudo green and cells in pseudo red. 
Features of capsule collagen, collagen, hepatocytes and bile duct shown in staining 
image (b) can all be identified in the SHG/TPEF image (c) respectively. Scale bar is 
100µm. 
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5.3.2 Comparison of liver surface among different stages 
Using the non-linear microscope, tile scan images of different liver surfaces 
were taken. As shown in Figure 24, (a) and (b-e) represent normal and stage 1 
to stage 4 fibrotic livers. Similar to what we observed in stained histopatholog-
ical samples, with the progression of liver fibrosis, accumulation of collagen 
fibrils was evident by stronger and more profound SHG signals detected both 
in liver interior and near surface region. In both regions, accumulation of bile 
duct area was also observable marked by the increase of dark red area. The 
progression of collagen distribution and bile duct proliferation to the surface 
with the increase of liver fibrosis can be easily observed in the images. Also, 
the thickening of liver capsule was observable in the fibrotic liver compared 
with normal liver tissues (Figure 24(a)). With these observations as the basic 
prove, next step we would quantitatively explore the relationship between liv-




Figure 24. Liver surfaces at different stages of liver fibrosis. Normal (a) and stage1 to 
stage 4 (b-e) fibrotic livers were imaged using non-linear microscope. With the pro-
gression of the disease, collagen (SHG) and bile duct area (TPEF) was accumulated 
both in liver interior and near liver surface. Surface capsule was thicker in fibrotic 
liver (b-e) compared to normal liver (a). Scale bar is 200µm. 
5.3.3 Liver surface regions definition 
In order to perform a quantitative analysis of liver surface features, we need to 
define liver surface and separate the surface area into regions that show differ-
ent properties. First, we rotated all images that we obtained into a top empty 
position, whereby there is no tissue sample from the top edge of the image and 
the liver surface is exposed on the top. Then combined SHG/TPEF images 
(Figure 25(a)) were separated into TPEF (Figure 25(b)) and SHG (Figure 
25(c)) channels to differentiate the autofluorescence of liver cells from the se-
cond harmonic signals of type I collagen. In the TPEF images, the liver 





region where there is autofluorescence, and the liver surface is the area below 
the boundary. Due to the morphological difference between capsule and other 
liver cells, we separate the surface area into two regions: the capsule region 
and the sub-capsule region. The definition of the two was defined in second 
harmonic images (Figure 25(c)). The SHG image was first converted into a 
binary image with regions that do not have signals shown as 0 and those with 
signals as 1. As the line boundary obtained from the red channel were moved 
pixel by pixel downwards, we observed an increase in the average amount of 
collagen (line average in Figure 25(d)) through a maxima and back to its ini-
tial value. This gave the thickness of the capsule region. The thick white line 
in Figure 25(c) is the capsule region in that image. Tracing parallel to this line, 
we went deeper into the tissue until we reached a depth where meaningful fea-
tures or trends could be observed. This gave a thickness to the sub-capsule re-
gion. In this study, we restricted this thickness to 150µm, since for application 
purposes, SHG/TPEF images have a limit on penetration depth into the tissue. 
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Figure 25. Definitions of capsule and sub-capsule regions in the liver surface. The 
combined SHG/TPEF image (a) was separated into TPEF (b) and SHG (c) channels. 
After finding the liver boundary in TPEF image (b), collagen content in the SHG im-
age (c) was calculated with increase of depth into the tissue (d) marked as line aver-
age. The depth at which there was a sharp decrease of collagen content (red arrow in 
(d)) was marked as capsule width (c), sub-capsule region was defined as the region 
parallel into the tissue. Scale bar is 100µm. 
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5.3.4 Four features extraction from both surface and interior tissue 
With capsule and sub-capsule regions defined, we proceed to extract features 
from the two regions on the surface together with the liver interior. The de-
fined thickness of the capsule region is a unique feature in the surface area. In 
the sub-capsule region of the surface area and in the interior, the parameters 
included in the study were total collagen, collagen in bile duct areas, bile duct 
proliferation and areas occupied by remnant hepatocytes. The feature extrac-
tion methods have been elaborated in methods, and features extracted have 
been exemplified as binary maps in Figure 26 based on the same sample im-
age in Figure 25. Total collagen (Figure 26(a)) is defined as the percentage of 
collagen that was presented in SHG images in the sub-capsule and interior ar-
ea. Bile duct proliferation (Figure 26(b)) was defined as the percentage of are-
as in either the sub-capsule or the interior that was occupied by bile duct cells. 
By overlapping Figure 26(a) and Figure 26(b), we obtained Figure 26(c), 
which is the percentage of abnormal collagen that was distributed in the bile 
duct area. The area occupied by remnant hepatocytes (Figure 26(d)) is the per-
centage of areas taken by remnant hepatocytes, defined as small surviving 
hepatocytes clusters that are surrounded by bile duct cells, in the sub-capsule 
or interior of liver. 
All four features extracted here were based on comparison with original 
stained tissue samples and are related to pathological readings. 
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Figure 26. Feature extraction from SHG/TPEF images. Based on the same 
SHG/TPEF image from Figure 25, the SHG image was segmented into a binary im-
age (a) representing total collagen in both capsule and sub-capsule regions, and liver 
interior. Bile duct area in the TPEF image was segmented into a bile duct mask (b). 
Combining the collagen mask and bile duct mask, the feature of collagen in the bile 
duct area was shown in (c). Hepatocytes clusters that were surrounded by bile ducts 
were segmented as potential remnant hepatocytes (d). 
5.3.5 Correlation between liver surface and interior 
To use the features extracted earlier to investigate the relationship between the 
liver surface and interior during fibrosis progression, we first tested the ap-
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plicability of our features in assessing fibrosis in the liver interior where most 
current studies were focused [118, 169]. Results (Figure 27(a)) showed that, 
with the natural progression of liver fibrosis indicated by the increasing time 
points (weeks 0, 2, 4, and 6) after BDL, total collagen, collagen in bile duct 
areas and bile duct proliferation increased with significance across different 
time points (p<0.05 among all time points in all three features). The dramatic 
increase of bile duct areas in this case is due to the specific model (bile duct 
ligation) we chose in this study. However, this feature is still applicable in 
other models. Comparing the difference of total collagen and collagen in bile 
duct areas, we can see that there is an almost consistent level of difference be-
tween the two, indicating a base level amount of normal collagen in the tissue, 
which is consistent with pathological findings. This also makes collagen in 
bile a more sensitive indicator to detect fibrosis in liver. Areas occupied by 
remnant hepatocytes also increased with fibrosis progression. However, be-
tween week 4 and week 6, no significant difference presented for the increase, 
making this feature only a sensible indicator for early stages of fibrosis. 
To verify that the four features we extracted are reasonable parameters to 
quantify liver fibrosis, the correlation of liver surface and interior was studied 
based on the features. Since these features were only present in the sub-
capsule region, the correlation coefficient between the sub-capsule region and 
the interior was calculated. Each plot in Figure 27(b) is the result of compar-
ing the same parameter value between that obtained in the surface images to 
the interior images at a particular depth of sub-capsule region. Three of the 
parameters studied showed an upward trend in correlation reaching a plateau 
stage at about 20µm. The parameter of remnant hepatocytes has a lower corre-
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lation, making it not a consistent feature for the two areas. Therefore, we de-
fine our depth of meaningful correlation between the surface and interior re-
gions as 20µm, beyond which no additional information can be obtained from 
the system. This would mean that, to monitor fibrosis from the surface of the 





Figure 27. Comparison of liver surface to interior. In the liver interior, the percentage 
of areas occupied by four different features was shown at different time points after 
performing bile duct ligation (a). All extracted features show a significant (p<0.05) 
upward trend with the progression of fibrosis among different time points except for 
remnant hepatocytes between week 4 and week 6. The correlation coefficient of fea-
tures between the liver interior and the surface is shown in (b). Features of total col-
lagen, collagen in bile duct and bile duct proliferation show an upward trend correla-
tion between surface and interior with the plateau of 20µm depth in the sub-capsule 
region. Remnant hepatocytes have a lower correlation. 
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5.3.6 Fibrosis distribution across the anterior liver surface 
Studies so far have been performed on the anterior surface of both the left and 
right lobes of liver tissues. To understand the relationship between different 
lobes in order to direct future sampling locations, we again calculated the cor-
relation coefficient of two lobes based on the four features at different depths 
of the sub-capsule region. The results (Figure 28(a)) showed that high feature 
correlation between the two lobes existed when the sub-capsule region reaches 
20µm and above based on three meaningful quantitative features of total col-
lagen, collagen in bile duct areas and bile duct proliferation. Thus, we can 
confidently monitor the progress of fibrosis with either lobe by scanning 
across their surfaces with no misrepresentation of the extent of fibrosis. 
It is intuitive that the scanning of liver surfaces would be done on the anterior 
of each lobe. Therefore all the quantitative analysis done so far was based on 
the anterior surface. However, in order to understand the fibrosis progression 
from a global perspective, we also investigated the correlation between anteri-
or and posterior liver fibrosis. Figure 28(b) showed that lower correlation ex-
isted between the anterior and posterior liver surfaces based on pathological 
features, also the correlation between posterior and interior is much weaker 
(data not shown). This indicated that liver fibrosis progresses in a heterogene-
ous manner toward anterior and posterior surfaces, with anterior surfaces pos-
sessing characteristics similar to the interior.  Since anterior surface is the 
main focus for surface scanning purposes, it is less important that there are no 
highly correlated anterior and posterior surface scans. 
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Figure 28. Quantification of the fibrosis distribution on the liver surface. (a) The cor-
relation coefficients of the liver left and right lobe surface features are shown. Except 
for the feature of remnant hepatocytes which are less correlated, all other surface fea-
tures have high correlations, and remain constant reaching the sub-capsule depth of 
20µm. (b) The correlation coefficient of the anterior and posterior surface features 
remains at a low level, indicating less correlation between these two surfaces. 
5.3.7 Features on liver surface as indication of liver fibrosis 
Now that the liver surface is highly correlated with the interior regarding the 
morphological features stated above, and the fibrosis distribution is uniform 
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across the liver anterior surface, we focused on the anterior liver surface to 
quantitatively assess liver fibrosis. A sub-capsule region of 20µm was shown 
as an example here, since it represents the minimal sampling amount for the 
meaningful correlation of surface and interior. With 50µm thickness of the 
tissue slices and the scanning length of 1380µm on the anterior surface, an ar-
ea of 69000µm2 on the liver surface was covered by each SHG/TPEF image, 
which is smaller than the equivalent surface area of 225625µm2 a non-linear 
endomicroscopy can scan [172]. The same four features (Figure 29(a)) were 
extracted in the sub-capsule region, with each quantified at different time 
points (week 0, 2, 4 and 6 after BDL). Conventional assessment based on the 
histopathological scoring system [124] was also performed in all tissue sam-
ples as a control comparison. Fibrosis was scored in five stages, 0, 1, 2, 3, 4, 
with stage 0 denoting no fibrosis and stage 4 denoting the most advanced fi-
brosis or cirrhosis. We found that, in the sub-capsule region (Figure 29(a)), 
features of total collagen, collagen in bile duct areas and bile duct proliferation 
have close agreement to that of the histopathological scores. The differences 
between different time points are also significant (P<0.05) except for total col-
lagen in early stages (between week 0 and week 2) due to its higher basal level 
of normal collagen in the sub-capsule region. Areas occupied by remnant 
hepatocytes, as a less correlated feature between surface and interior, did not 
show an observable trend with the progression of fibrosis in the surface; how-
ever, as in the interior, remnant hepatocytes on the liver surface are a good 
indicator for the occurrence of fibrosis. 
 96 
As suggested by Buschmann, R.J etc [14], capsule collagen width can be used 
as a measurement of fibrosis, also, as capsule thickening in liver disease is 
known to occur. Here, we quantified the capsule collagen width based on our 
capsule definition (Figure 29(b)) as a unique feature in the surface area. The 
trend of increasing thickness with fibrogenesis in our model confirmed the 
non-quantitative findings in the previous study [14, 173]. However, even 
though we can differentiate the early and late stages of BDL, we cannot make 
clear distinction between each consecutive stage based on this feature. Due to 
the inappreciable increase in width between each two-week interval, this can 
hardly be used as a sensitive means to monitor fibrosis in a two-dimensional 
situation. Potentially with the 3D structure of collagen distribution, we might 
be able to implement more aspects of capsule feature for detailed quantifica-
tion. Therefore, quantification of liver fibrosis on the liver surface only works 
when SHG and TPEF microscopies enable the quantitative imaging of liver 
surfaces beneath the capsule. 
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Figure 29. Quantification of liver fibrosis progression on the liver surface. (a) Quanti-
fication results of different features extracted from SHG/TPEF images obtained at 
different time points after BDL showed that there is an upward trend with the pro-
gression of fibrosis regarding all features. Significant differences among different 
time points exist for collagen in the bile duct area and bile duct proliferation in the 
sub-capsule region. This upward trend also agrees with the histopathology scoring 
results of the same stained tissue samples. (b) Capsule width in the capsule region 
also increases with the progression of fibrosis, with more significant increases in the 
late stage of fibrosis. 
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5.3.8 Potential application in surface scanning 
With the anterior liver surface pertaining the consistent features as in the liver 
interior, we compared the normal and fibrotic anterior liver surface by scan-
ning on the front size of the perfused liver using reflective mode SHG and 
TPEF, shown in Figure 30. In the capsule region in normal liver (Figure 
30(a)), capsule collagen was condense, and regularly aligned compared with 
that in fibrotic liver (Figure 30(c)). This lose alignment of capsular collagen in 
fibrotic tissue could explain our observation of increased capsular width in the 
tissue slices. In the sub-capsule region, 20µm below the capsule region, nor-
mal liver (Figure 30(b)) has well-organized hepatocytes and no clear collagen 
presence. While in the BDL fibrotic liver (Figure 30(d)), bile duct prolifera-
tion is obvious, which destruct the alignment of functional hepatocytes. Ab-
normal collagen is also present around the bile duct cells, a clear indication of 
fibrosis. All these features are consistent with the observation in the liver tis-
sue slices, although in the reflective mode images, SHG signals are much 
weaker, evident by the less amount of collagen presence in the fibrotic liver. 
With these feature pattern differences between normal and fibrotic liver sur-
face, we are potentially able to quantitatively monitor liver fibrosis progres-
sion on the liver surface. 
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Figure 30. Liver anterior surface scanning. Front size images from liver surfaces were 
obtained by reflective SHG and TPEF imaging. 3-D projections of capsule regions 
were shown in both normal (a) and fibrotic liver (c). Irregular and loss alignment of 
capsule collagen distribution in fibrotic liver is observed compared to normal liver. 
Sub-capsule region images were obtained 20µm below the capsule region in respec-
tive normal (b) and fibrotic (d) liver tissues. Features of bile duct and abnormal colla-
gen proliferations were present in fibrotic liver (d) compared to normal liver (b) 
where only well-organized hepatocytes present. Scale bar is 100µm. 
 100 
5.4 Conclusion 
We discovered a strong correlation between liver fibrosis progression on the 
anterior surface and the interior based on quantitative analysis of morphologi-
cal features in both regions. Using SHG and TPEF microscopes, we demon-
strated the feasibility of monitoring liver fibrosis progression on the anterior 
surface with the BDL animal model by comparing with the conventional his-
topathological scoring system. We also discovered a uniform distribution of 
quantitative liver fibrotic features, such as total collagen distribution, bile duct 
proliferation and collagen in bile duct areas, across two main lobes of the ante-
rior liver surface, which gave us confidence to quantitatively monitor the pro-
gress of liver fibrosis on different lobe surfaces. With all this information laid 
out, we are now one step closer to applying reflective or endoscopic imaging 
of the liver to diagnose and stage liver fibrosis, which can potentially be used 
clinically to complement or eventually, avoid the more invasive liver biopsy. 
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Chapter 6 Liver fibrosis surface assessment and window model es-
tablishment 
6.1 Introduction 
For liver fibrosis diagnosis and assessment, currently, biopsy still represents 
the gold standard with its known complications and drawbacks [4, 52, 102, 
103]. Other non-invasive imaging methods, such as ultrasonography [162], 
transient elastography [163] and magnetic resonance elastography (MRE) [60, 
164] have shown potential for fibrosis assessment and staging. However, they 
are only based on liver stiffness measurements (LSM), which is not directly 
comparable with morphological features that biopsy samples obtain. Their 
sensitivities are also less satisfactory with current studies. 
To develop a less invasive imaging methods for fibrosis assessment and to ex-
tract comparable morphological features, SHG/TPEF imaging modalities were 
studies on their application for information extraction and quantification of 
fibrotic features. Due to their limited penetration property, surface information 
of liver organ was targeted. To incorporate the findings we have discovered in 
earlier studies that liver surface has a strong correlation with liver organ fibro-
sis distribution and that by examining liver surface alone, we can quantify the 
liver fibrosis degree, we now propose to apply such findings into the live ani-
mal imaging to explore the full potential of in vivo monitoring fibrosis pro-
gression in laparoscopy application. 
The first transparent window chamber was developed by Sandison in 1924, 
implanted in the ear of a rabbit, which allowed continuous, non-invasive, 
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long-term monitoring of angiogenesis during wound healing [174]. Currently, 
with the development of multiphoton laser scanning microscopy, application 
of such three-dimensional high resolution imaging method in the biomedical 
study triggered more chamber window designs. The design of intravital hepat-
ic imaging chamber especially allowed the investigation of in-vivo dynamics 
of hepatic activities in rodents without additional treatments [175]. Technical-
ly, the chamber can be applied to the animal as long as the animal is alive, and 
for current design, the animal can be imaged with the chamber for as long as 6 
hours. 
For live imaging of rat liver surface in our study, an intravital window based 
imaging chamber was designed to apply on rat abdomen for fibrosis monitor-
ing. Cross modality comparison between SHG/TPEF imaging methods and 
MRI imaging methods for fibrosis assessment was proposed on the window 
rat model. Therefore, different chamber materials were searched and tested for 
compatibility purpose. Different animal fibrosis models were also explored in 





6.2 Materials and Methods 
6.2.1 Window intravital chamber design 
The idea of the liver chamber is to open a window in the abdomen of the rat to 
obtain in vivo images of the liver surface by means of optical microscopy 
methods. To achieve this, window intravital chamber prototypes were drawn 
using Solidworks (Dassault Systèmes SolidWorks Corp.), and then sent for 
fabrication in plastic. After examining the prototypes, improvements were 
made to the corresponding design, and the final product would be fabricated in 
titanium due to its good biocompatibility and light weight. 
Based on the previous chamber design used on mice by National Taiwan Uni-
versity [175], and with continuous help from Professor Dong’s group who de-
signed the chamber, we came up with a few prototypes for the chamber com-
ponent used for rats. The dimension of the rat liver (Figure 31) limits the max-
imum radius of the chamber. Due to the asymmetric structure of the rat liver, 
we proposed to attach window chamber over the left lobe of the liver for the 
imaging exposure. For flat attachment of the liver to the window chamber, a 
window diameter of less than 25mm was proposed. 
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Figure 31. The front view of the abdomen of the rat, demonstrating the area available 
for the chamber attachment. L, R represents left lobe and right lobe of liver respec-
tively. 
6.2.2 Material search for window chamber 
In order to apply intravital SHG microscopy and MRI on the same subject in 
the same period of time, the imaging chamber should be made of MRI artifact-
free materials. As apposed to the design employed on mice study [175], we 
were trying to find a non-glass MRI artifact-free polymer that possess property 
of biocompatibility, good mechanical strength and good optical properties. 
Polyethylene terephthalate (PET), with its high transparency and similar mag-
netic susceptibility with soft tissue, was identified as the potential candidate 
for replacing glass. 
Signal Scattering from Fluorescent Microbeads: 
2.5µm diameter microbeads ( InspeckTM Orange (540/560) microscope Image 




degree of signal scattering. 40X images of microbeads kept under glass cover-
slip and PET cover-slip were captured using Zeiss LSM 510 Meta.  
Resolution study with SHG signal from muscle tissue: 
30 µm thickness Rat pectoral muscle tissue was prepared. The images were 
taken by Zeiss LSM 510 Meta, with Plan-Neofluar 20x lens, The SHG chan-
nel with 900nm excitation and 450nm emission was applied, together with au-
tofluorescence channel. 
6.2.2.3 Resolution study using cervical cancer cells 
HeLa cells labeled with pDsRed in ER was cultured on glass and PET cover 
slip, and observed under autofluroscence with excitation 543nm and emission 
bandpass filter 565-615nm. The image was taken using Zeiss LSM 510 Meta 
with Plan-Neofluar 40x lens.  
Spectrogram comparison: 
The intensity of light transmitted through different cover slip was recorded. 
The result was compared to the value with no cover slip in. The transmission 
spectrum was obtained by dividing the signal with cover slip to that of no cov-
er slip. 
6.2.3 Application of window intravital chamber on rats 
Pre-surgical preparation: 
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Surgical instruments were autoclaved at 121°C for 22 mins. Autoclaved items 
were dated, labelled and used within a week. Surgical space was disinfected 
with 70% ethanol. 
Preparation of animal for surgery: 
The male Wistar rats were transported to the preparation room and sedated 
using ketamine and xylazine (75mg/kg ket/ 10mg/kg xyl I.P). Animals were 
then shaved on the abdomen and fur was removed with a vacuum evacuator. 
Operation site was swabbed with 1% cetrmide followed by 0.05% chlorhexi-
dine. The rat were injected with 5ml 0.9% NaCl S.C perioperatively. The ab-
domen was then draped and finally swabbed with povidone iodine.  
Intravital chamber installation: 
The incision of the upper abdomen was sutured, leaving a part open to create a 
circled wound to position the liver window device inside the abdominal wall. 
Prior to installing the lid, a cover glass / transparent membrane was adhered 
around the outer rim by a biocompatible tissue adhesive Histoacryl (B. Braun 
Melsungen AG, Germany). The cover glass / transparent membrane serves as 
the observation window of intra-vital activities. The lid was then sutured 
through the small holes on the ring to the skin and peritoneum. To ensure tight 
contact of the liver surface with the cover glass / transparent membrane and to 
minimize motional artifacts associated with heartbeat and respiration, tissue 
adhesive was applied to the edge of the lid to adhere the liver to the imaging 
chamber. Fluid therapy was given perioperatively with 5 - 7 ml of potassi-
um/sodium chloride premix injection. 
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6.2.4 Image acquisition from window chamber animal model 
Non-linear imaging system set-up is the same as presented in Chapter 5, 5.2.3. 
The rat installed with the window intravital chamber was kept in the supine 
position with the intravital chamber fitted into the U-shaped groove of a steel 
plane, which is screwed tight to another round steel plane that fits into the mi-
croscope stage. The round stage was also screwed to the microscope stage for 
stability. In this manner, the rat can be firmly attached for live imaging pur-
poses. 
Non-linear microscopy set-up was exactly the same as that has been used in 
Chapter 5 (Figure 22). Reflective mode SHG and TPEF imaging was applied 
during live imaging of rats. 
6.2.5 Rat toxicity model establishment 
Male Wistar rats at an average weight of 220g were housed two per cage in 
Biological Resource Centre (BRC) of Biopolis A*STAR with free access to 
laboratory chow and water in a 12:12h light/dark schedule. The rats were ad-
ministrated with intra-peritoneal (ip.) injection of Thioacetomide (TAA) 
200mg/kg of body weight with PBS, three times a week. 
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6.3 Results and Discussions 
6.3.1 Window intravital chamber for rat liver live imaging 
To achieve the goal of live imaging for rat liver, the window intravital cham-
ber diameter was fixed to the liver exposure size of less than 25mm diameter. 
The reason for choosing a round shape for the chamber is that the rounded 
shape is easier to stitch on rats’ liver without worrying about the dimension of 
the shape, and less abrasion will be caused by the edge of the chamber. 
After fixing the shape, the first two prototypes (Figure 32) we tested were the 
ones that were designed by National Taiwan University for mice, with two 
components design (Figure 32(b)) published in a recent paper [175]. We 
changed the size of those two designs to fit rats. The one component chamber 
(Figure 32(a)) was designed to be sutured to the skin through the eight holes 
along the chamber edge. Round indentation on the surface was designed to 
connect to glass / polymer cover slip with glue. The liver would be in touch 
with the cover slip surface through gravity. Since both mouse and rats have 
two layers of skin, we found it would be more stable if we have two compo-
nents for the chamber, so that both layers can be sutured to the chamber com-
ponents. For this reason, we tested two-components chamber design (Figure 
32(b)). The inner lid was designed to be sutured and glued to the muscle layer 
in front of the peritoneum. A round cover slip would be glued onto the inden-
tation of the inner lid on the bottom. The outer lid would be screwed into the 
inner lid to clamp the tissue layers from liver to skin. It would then be sutured 
to the skin. 
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Figure 32. Two original prototypes of window intravital chamber designs. Prototype 
(a) has one component, was designed to be sutured to the rat skin and glued to the 
liver surface with cover slip glued on the top. Prototype (b) has two components, with 
inner lid (left) sutured to the muscle layer with cover slip glued to the bottom of the 
chamber, and outer lid (right) screwed the inner lid and sutured to the tissue layer of 
the skin. 
The two-components design has the advantage of stability. To improve on the 
quality of the images and to prevent the scratches on the cover slip from the 
rats, we further designed three novel prototypes of the intravital chamber. As 
shown in Figure 33(a), a screwing cover (right) was introduced in the original 
two-components design, with the whole compartment made of light material. 
For the potential application on MRI imaging, the cover slip was proposed to 
be removed during imaging to reduce the artifacts caused by glass material. 
Therefore, another designed was introduced (Figure 33(b)) to include a re-
movable part (right) that attached to the glass cover slip. This also solves the 
problem of scratching by the rats. Glass window can be easily plugged in for 
optical microscopy and taken out and replaced by other materials for the re-




we further removed the screwing part of the removable window. Instead, a 
small protrusion on both sides of the chamber was introduced for window 
plug-in. Making use of the elastic property of the material, when the window 
plug-in was pushed into the frame, the protrusion would then slip into the 
small hole in the frame. To remove the window plug-in, forceps would be 
used to hole the ends with the protrusion and to pull it out. To still maintain 
the stability of the intravital chamber, double layer stitching was introduced 
during surgery. Therefore, only one stitching chamber would be needed for the 
design. 
 
Figure 33. Three novel prototypes of window intravital chamber designs. Prototype 
(a) has three components, with inner lid (left) and outer lid (middle) securing the 
chamber on the rat abdomen and screwing cover (right) applied to the outer lid to 
protect the cover slip. Prototype (b) has three components, with inner lid (left) and 
outer lid (middle) same as prototype (a) and window screw-in (right) glued to the 
cover slip at the indentation on the bottom. The window with cover slip can be 
screwed in and out to inner lid upon different usage. Prototype (c) has two compo-





to the cover slip on the bottom. It can also be plugged in and out from the window 
frame upon different usage. 
All the prototypes designed so far can meet the requirement of stability and 
easy handling. However, since the position of the cover slip on the two- and 
three-components designs was at the bottom of the intravital chamber, the 
movement of the objective lenses on the viewing window was restricted by the 
radius of the chambers. After researching the objective dimensions of the 
lenses in the lab (Table 4) and considering the optimal viewing size of the rat 
liver (less than 25mm), we discovered that, based on the current design, the 
objective lenses cannot cover a large enough surface area for fibrosis assess-
ment. Considering this, we proposed modifying the original one component 
design to allow flat viewing surface, so that the object lenses can move freely 
on the window chamber, allowing larger coverage of the liver surface for im-
aging. 
Table 4. Dimensions of various objectives available in the laboratory. 




Olympus UPLASPO 20X 24.0 0.60 
Olympus LCACHN 20XPHP 24.0 3.20 
Zeiss Plan-Apochromat 10X / 
0.45 
22.5 0.193 
Zeiss Plan-Apochromat 63X / 




To increase the viewing size of the liver surface and take advantage of stand-
ard glass cover slip shape, we designed the new one-component window 
chamber with a square compartment for holding cover slip (Figure 34). This 
would also benefit the stability of glass cover slip on the chamber, as a larger 
glue area can be applied between cover slip and the chamber ring. Double 
stitches of the two skin layers were applied during the installation of the 
chamber to secure the chamber. The final available viewing size was fixed to 
diameter of 23.5mm and can be reached by all sized objective lens freely. 
 
Figure 34. Window intravital chamber design and application on rats. (a) Design of 
the one component intravital chamber with square indentation on the surface for cov-
er slip attachment. The dimensions were marked with millimeter. (b) Installation of 
titanium chamber on rat’s abdomen, stitches and glues were employed to stabilize the 
chamber, lower left lobe liver was exposed. 
6.3.2 Material for window intravital chamber cover slip 
With the intension of building a live imaging animal model for fibrosis surface 
assessment, and the potential for cross-modality comparison with Magnetic 
Resonance Imaging (MRI), we researched on the alternative MRI artifact-free 
 113 
materials to allow Apparent Diffusion Coefficient (ADCs) measurement at the 
same time with optical imaging for liver fibrosis. Polymer PET was suggested 
for this purpose due its biocompatibility [176] and its transparent property. 
Possessing similar susceptibility to soft tissue, PET has also been suggested to 
have no magnetic field interactions [177]. Its optical properties were further 
studied. 
Autofluorescence signals were first tested with fluorescent microbeads. Signal 
scattering (Table 5) of fluorescent microbeads and images of fluorescent mi-
crobeads (Figure 35) under both glass cover slip and PET cover slip were 
compared. Signal scattering was estimated by: Scattering Ratio=
. 
As indicated by the table, glass has much better signal intensity compared to 
PET, with much less scattering. This was also shown in the Figure 35. Using 
the same microbeads, microbeads signals under glass cover slip (Figure 35(a, 
d)) was much stronger than under PET cover slip (Figure 35(b, e)), with the 
beads’ round shape easily identifiable. To improve the signal intensity, image 
set-up for optimal images under PET cover slip was employed by increasing 
the detector gain. Although signals were much stronger (Figure 35(c, f)) com-
pared with earlier set-up, the scattering also increased at the same time, shown 





Table 5. Scattering Ratio from beads under glass and PET cover clip. 
 Ratio SD 
Glass 77.90% 0.019 
PET - Same parameter with glass 43.20% 0.056 
PET- optimized parameter for PET 12.00% 0.037 




Figure 35. Fluorescent images of 100% microbeads under both glass and PET cover 
slips. Images of microbeads under glass cover slip (a) and under PET cover slip (b) 
with the same image set-up and parameters. Image of microbeads under PET cover 
slip with optimized parameter for PET. (d), (e) and (f) are the range indicator of the 
same image as (a), (b) and (c) respectively. Background was shown as blue, weak 
signal was shown as black, strong signal was shown as white and saturated signal was 






Next, we tested the SHG signals from muscle tissues coming through both 
glass and TEP cover slips. For liver fibrosis assessment, SHG signals are very 
important, as they are the most important indicator for fibrosis occurrence 
shown in the earlier study. Under glass cover slip (Figure 36(a)), the SHG 
channel has high resolution and the muscle fiber striation with band width ap-
proximately 2µm can be identified clearly. Under the same detector gain, 
muscle tissue under PET (Figure 36(b)) had a weaker signal, although the 
muscle striation can still be seen. By optimizing the gain parameter in the mi-
croscope, the intensity of SHG signal increased and the striation can be easily 
spotted (Figure 36(c)). Based on the observation, SHG signals have a better 
presentation under the PET cover slips than the autofluorescence signals. 
However, the signal intensity is still much weaker than under glass cover slip. 
 
Figure 36. SHG images of muscle tissue striation under both glass and PET cover 
slips. (a) SHG signal under glass cover slip. (b) SHG signal under PET cover slip, 
with the same parameter as that under glass. (c) SHG signal under PET cover slip, 
with increased gain. Scale bar is 10µm. 
To investigate the cellular level signal resolution under both glass and PET 
cover slips, stained cervical cancer cells were tested in both situations. The 
pDsRed labeled endoplasmic reticulum (ER) of HeLa cells was observed un-
der different cover slips with Plan-Neofluar 40x lens. As shown in Figure 
! " #
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37(a), The ER can be distinguished in the cells under a glass cover slip. How-
ever, with the same imaging set-up, no cell can be observed under PET cover 
slip (image not shown). By increasing the detector gain of the microscope, the 
ER structure of the cells can be observed (Figure 37(b)), although the image 
was much more blurry compared with that under glass cover slip. A spot-like 
artifact with size of approximately 2µm diameter was also observed under 
PET cover slip (Figure 37(b) with arrow). It was suspected that due to the 
holes and chains configuration of PET polymer, the holes in PET might give 
rise to the dot artifact. This artifact would compromise the later fibrosis quan-
tification, especially under live imaging, the artifact would be even more 
prominent. 
 
Figure 37. Imaging of cervical cancer cell with pDsRed labeled endoplasmic reticu-
lum under both glass and PET cover slips. (a) Image taken under glass cover slip. (b) 
Image taken under PET cover slip with arrow pointing to the spot like artifact. Scale 
bar is 10µm in (a) and 2µm in (b). 
Finally, the transmission spectrum of glass and PET was compared. As shown 
in Table 6, the transmission percentage of PET is on average about 10% lower 
than glass under all wavelengths tested. This loss of signal during imaging 
x! x"
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would compromise the images taken from liver tissue, and possibly make it 
hard for feature extraction in both SHG and TPEF channels. With the weaken-
ing of signal from reflective imaging compared to transmission imaging, this 
loss of signal would exacerbate in liver surface assessment. 
Table 6. Transmission percentage of glass and PET at specific wavelength 
 
In conclusion, based on the comparison of glass and PET cover slip optical 
properties so far, we found it is to our benefit to stick with glass cover slip de-
sign. Since the optical property delivered by PET was sub-optimal, it would 
deteriorate the final purpose of liver surface fibrosis assessment. Therefore, 
the final intravital chamber was designed in one component with square glass 
cover slip as the viewing media. 
6.3.3 Window intravital chamber installation on rats 
After deciding on the one-component design with glass cover slip and titanium 
for the intravital chamber material, the whole imaging stage was redesigned in 
Applied signal and Wavelength 
(nm) 
Glass 
PET Difference in 
Mean 
Mean SD Mean SD 
Flurescence Green (500 – 550) 90.6% 0.047 79.6% 0.081 11.0% 
Flurescence Red (550 – 630) 90.0% 0.056 79.0% 0.086 11.0% 
SHG (440-460) 92.6% 0.033 81.2% 0.084 11.4% 
SHG (890- 910) 92.5% 0.022 82.7% 0.084 9.8% 
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stainless steel to hold the chamber and to fit on the LSM 510, Carl Zeiss mi-
croscope. As shown in Figure 38, the imaging stage was made of three com-
ponents. The U-shape steel plate (Figure 38(a)) would secure the intravital 
chamber attached to the rat skin, and screwed tight to the ring holder. With 
them fastened together, the ring holder would be placed on steel stage (Figure 
em(b)), and be screwed tight from the front end of the steel stage. The fully 
assembled imaging stage was presented as in Figure em(c). It would be direct-
ly placed on the Carl Zeiss microscope to expose the middle part for imaging. 
 
Figure 38. Imaging stage customized for window intravital chamber live imaging. 
Components designed to secure intravital chamber is shown in (a) with U-shape hold-
ing the chamber and screwed to the ring holder on the left. Steel stage (b) is used to 
secure the ring holder and the assembled stage is shown in (c). 
To apply the window intravital chamber and to eventually put rat on imaging 
stage ready for live imaging, a few steps were taken. As described previously 
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in materials and methods, to optimize the liver exposure size for live imaging, 
lower left lobe of liver was targeted for exposure. The rat was put in a supine 
position after anesthesia on the operational stage. A small incision on the low-
er left abdomen was firstly made to exposure the area (Figure 39(a)), and then 
window intravital chamber with glass cover slip attached was double layer 
stitched to the open abdomen. Liver surface was exposed through glass cover 
slip. U-shape steel plate and ring holder were then screwed tightly to the in-
travital chamber (Figure 39(b)), and lastly placed on the imaging steel stage 
(Figure 39(d)). After fastening the ring holder to the imaging stage, the rat 




Figure 39. Accommodation of window intravital model rat on imaging stage. Liver 
was exposed (a) on the lower left abdomen, and then sutured to window intravital 
chamber (b). After tightly immobilized on U-shape plate and ring holder (c), rat with 
intravital chamber was placed on the imaging stage (d), ready for live imaging. 
6.3.4 Live imaging of window model rat 
Following the previous study of BDL rat fibrosis assessment, we proceeded 
with the intravital window model application on BDL rat model. After bile 
duct ligation operation was carried out, intravital window chambers were in-
stalled on rats’ abdomen different weeks after the operation. However, from 
two to three weeks after bile duct ligation operation, ascitics in the peritoneal 
cavity began to accumulate in the operated rats, causing the difficulty in the 
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chamber installation. Meanwhile, the ascitics also created a gap between the 
chamber viewing window and the liver tissue. The mis-attachment eventually 
impaired the imaging quality of the liver tissue, making this live imaging 
model ineffective. 
To solve this problem and to introduce a viable animal model for liver fibrosis 
live imaging, we proposed a liver toxicity model as apposed to bile duct pro-
liferation model to induce liver fibrosis. Thioacetamide (TAA) induced liver 
fibrosis model was then established on rats as described in methods to incor-
porate into the live imaging project. 
Liver fibrosis features of the toxicity model were first observed in fixed tissue 
reflective images, where liver surfaces of fixed samples of normal (Figure 
40(a,c)) and fibrotic livers (Figure 40(b,d)) were compared. As shown in the 
figure, with the progression of liver fibrosis, capsule collagen in fibrotic liver 
(Figure 40(b)) increases drastically compared to normal liver (Figure 40(a)). 
Almost no collagen in sub-capsule region could be identified in normal liver 
(Figure 40(c)), while abundance of fibril collagen was present in fibrotic liver 
tissue (Figure 40(d)). The sub-capsule tissue structure of normal liver was 
tightly aligned and sinusoids were easily identifiable, while in the fibrotic liv-
er, the alignment of hepatocytes were much loser and a loss of autofluores-
cence signal was observed, especially surrounding collagen proliferation area. 
This could due to the block of autofluorescence signals reflection from thick 
layer of capsule collagen in fibrotic tissue. With these observations in tissue 
imaging, live images were further generated and compared. 
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Figure 40. Surface scanning of TAA model liver tissues. Reflective SHG and TPEF 
images of liver surfaces were obtained from both normal (a,c) and fibrotic (b,d) liver 
tissues. 3D projection of capsule collagen of both normal (a) and fibrotic (b) liver 
surface were shown, and increase of collagen in fibrotic liver were evident. Sub-
capsule region images were obtained respectively. Presence of significant amount of 
collagen and loss of tissue structure can be observed in fibrotic tissue (d) compared to 
normal liver (c). Scale bar is 100µm. 
Rats of different weeks after TAA injection were installed with intravital win-
dow based imaging chamber for live imaging. Here, live imaging results of 
three time points and three different rats after fibrosis induction were shown. 
3D projection of normal rat liver capsule (Figure 41(a)) and sub-capsule tissue 
image (Figure 41(b)) were compared with that from fibrotic livers both 10 
weeks after TAA treatment (Figure 41(c) and Figure 41(d)) and 14 weeks after 
TAA treatment (Figure 41(e) and Figure 41(f)). An increase of capsule colla-
 124 
gen distribution on the liver surface was evident by the increasing amount and 
the intensity of SHG signals from collagen. The increasing presence of sub-
capsule collagen (Figure 41 (d,e,f)) was also in agreement of fibrosis progres-
sion, even though the amount of collagen seen in live images were less thank 
in fixed tissue images. Meanwhile, with the increase of liver fibrosis, tissue 
structure in the sub-capsule region was getting less distinguishable, and sig-
nals from liver cells was much weaker. In very late stage of fibrosis or cirrho-
sis (Figure 41(f)), cellular structure was hardly identifiable compared to well 
aligned hepatocytes in normal healthy rat liver (Figure 41(d)). The loss of 
TPEF signals and the disruption of cellular structure in fibrotic liver could be 
caused by apoptosis and necrosis of hepatocytes, as they are the main source 
of autofluorescence in liver tissue. With the fibrosis progression, the harden-
ing of liver could also put more pressure on the blood flow, which interrupted 
the signals of hepatocytes autofluorescence. The less and weaker SHG signal 
collected in live imaging (Figure 41(f)) compared to signals from fixed tissue 
(Figure 40(d)) could also be contributed to the interference of blood flow and 
animal breathing during live imaging. 
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Figure 41. Live imaging of window model rats. Normal rat (a,d), rats of 10 weeks 
(b,e) and 14 weeks after TAA injection (c,f) were installed with intravital imaging 
chamber and placed on microscope for live imaging. 3D projections of capsule colla-
gen (a,b,c) were recorded together with sub-capsule imaging (d,e,f) of both collagen 
and tissue. Increase of collagen distribution in both capsule and sub-capsule regions 
was evident by the increasing amount of SHG signals. Tissue structure was less 
aligned and signals were dropping with the increase of fibrosis. Scale bar is 100µm. 
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6.4 Conclusion 
Based on the results from previous study that fibrosis distribution on liver sur-
face is similar to that of the liver interior, we focused on the application of 
such discovery in live imaging in this chapter. Intravital imaging based liver 
chamber was designed and developed for live rat imaging purpose, and has 
been applied on both normal and fibrotic rats for in vivo liver fibrosis monitor-
ing. Toxicity induced liver fibrosis model was developed as opposed to previ-
ously used Bile Duct Ligation model for the ease of chamber installation and 
imaging quality control. With the observation of live images, we discovered 
similar fibrosis features to what we observed in both transmission and reflec-
tive tissue imaging, including increase of capsule collagen distribution on liver 
surface, increase of sub-capsule fibril collagen deposition within the liver tis-
sue and disruption of tissue structure with the fibrosis progression. With these 
features present in both animal models and the ability of detection of features 
in live imaging, we are currently able to monitor fibrosis based on this win-
dow animal model.
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Chapter 7 Conclusion 
This thesis documented the study of liver fibrosis using non-linear optics mi-
croscopy. Rat fibrosis models were established as animal study platform, and 
tissue level imaging was applied. To use non-linear optics methods to study 
liver fibrosis, images of unstained liver tissues taken were compared to con-
ventional histological stained slice tissues. Four morphological features from 
digitized Second Harmonic Generation (SHG) / Two Photon Excitation Fluo-
rescence (TPEF) images were extracted from tissues, and a standardized quan-
tification system in liver fibrosis assessment was developed based on those 
features. After comparing with the conventional ‘gold standard’ histopatholog-
ical scoring system, we demonstrated the feasibility of SHG/TPEF micro-
scopes in monitoring liver fibrosis progression by the quantitative assessment 
we developed. The quantitative and standardization nature of the SHG/TPEF 
imaging modalities allows for future application in diagnosis and prognostica-
tion of disease complications and to assist biopsy reading by minimizing the 
intra- and interobserver discrepancies through standardized features quantifi-
cation that is widely accepted by pathologist for staging. The non-staining re-
quirement of such imaging methods also gave the potential for in vivo fibrosis 
assessment given its ability to extract cellular level features. 
To achieve the goal of in vivo fibrosis assessment, we focused on the liver sur-
face, where the imaging scanning would be performed. Due to the limited in-
trinsic penetration depth of SHG/TPEF imaging modalities in opaque liver 
tissue, liver surface features were studies and compared to the general features 
we extracted in interior liver. In Chapter 5, we discovered a strong correlation 
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between liver fibrosis progression on the anterior surface and the interior 
based on quantitative analysis of morphological features in both regions. By 
comparing with the conventional histopathological scoring system, we demon-
strated the feasibility of monitoring liver fibrosis progression on the anterior 
liver surface. A uniform distribution of quantitative liver fibrotic features, 
such as total collagen distribution, bile duct proliferation and collagen in bile 
duct areas, was also discovered across two main lobes of the anterior liver sur-
face, which gave us confidence to quantitatively monitor the progress of liver 
fibrosis on different lobe surfaces. 
Following the discovery that fibrosis distribution on liver surface is similar to 
that of the liver interior, application of such discovery was explored in live 
imaging in Chapter 6. Intravital imaging based liver chamber was designed 
and developed for live rat imaging purpose, and has been applied on both 
normal and fibrotic rats for in vivo liver fibrosis monitoring. Toxicity-induced 
liver fibrosis model was developed as opposed to previously used Bile Duct 
Ligation model, for ease of chamber installation and imaging quality control. 
In live imaging of rat liver through window chamber, we discovered similar 
fibrosis features to those we observed in both transmission and reflective tis-
sue imaging, including increase of capsule collagen distribution on liver sur-
face, increase of sub-capsule fibril collagen deposition within the liver tissue 
and disruption of tissue structure with the fibrosis progression. With these fea-
tures present in animal fibrosis models and the ability of detection of features 
in live imaging, we are currently able to monitor fibrosis based on this win-
dow animal model. 
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Chapter 8 Recommendations for Future Research 
8.1 Antifibrotic drug effect monitoring using window based rat model 
The search for antifibrotic drug has been ongoing, and pre-clinical trial on 
small animals has been an important step for drug discovery and development 
[178]. It is generally accepted that the use of sufficient numbers of animals 
(n=8-15 per group depending on the model) is critical to overcome the indi-
vidual heterogeneity in fibrosis progression. However, it is costly to have a 
large sample size of animal and to sacrifice animals at different time points 
after the treatment would further complicate the analysis. Based on the intravi-
tal window based imaging chamber development in Chapter 6, and the future 
complete and extensive fibrosis assessment in different stages, a window 
based rat model could be used for live fibrosis staging and monitoring. A fully 
automated index for fibrosis could be generated based on the toxicity model 
fibrosis assessment, and applied in the antifibrotic effect monitoring. Using 
this model, drug effects study would be directly monitored on an individual 
rat, saving the cost of conducting different time points on different animal in 
each group. The results would also be better represented for drug effect study, 
and the effect on different individual can be studied in detail. 
8.2 In vivo study of bone marrow derived Mesenchymal stem cells 
(MSCs)’s function in liver fibrosis 
Bone marrow derived cells have been shown to contribute to fibrosis in differ-
ent organs [179-181]. However, the function of Mesenchymal stem cells de-
rived from bone marrow in liver fibrosis has been disputable, with some study 
 130 
claiming it to have antifibrotic effect [182] while others claiming it to have 
contributed to the proliferation of hepatic stellate cells, which further exacer-
bate fibrosis [183]. To truly understand the effect of MSCs in the fibrotic liver, 
in vivo monitoring of fibrosis progression after the injection of BM or MSCs 
would be desirable. Using our window based rat model, liver fibrosis can be 
directly monitored on a continuous basis before and after the treatment, there-
fore, would help to solve the dispute of the arguments. Using contract en-
hanced dyes or genetic modified MSCs cells for the treatment, we can even 
locate the cells and trace the real-time cell migration and differentiation of 
MSCs in the fibrotic liver. This would provide strong argument for the real 
function of this cell type, and possibly direct future fibrosis treatment. 
8.3 Virtual biopsy based on liver surface information extracted through 
non-linear optical endoscope 
With the current development of non-linear endomicroscope [172, 184] with 
SHG and TPEF modalities build in, the application of surface scanning can be 
directly tested with the device. Instead of using a window-based rat model, rat 
liver fibrosis can be directly monitored using a non-linear endoscope for liver 
surface scanning. This would also allow access to larger liver area and as-
sessment of different lobes. For repeated scanning, a device similar to a vascu-
lar shunt port can be implanted in rat abdomen for easy access and to relief the 
pain and damage to the skin. Cross modality comparison would also be made 
possible through this approach. This study would shed light on the future ap-
plication of such device in clinical long-term follow up on liver fibrosis treat-
ment to replace more invasive and damaging liver biopsy.
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